var title_f4_62_5088="Algorithm management TTP-HUS";
var content_f4_62_5088=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 585px\">",
"   <div class=\"ttl\">",
"    Algorithm: suggested management of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 565px; height: 611px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The clinical course of patients with TTP may be complex and cannot be easily represented by a single diagram. Continued search for alternative etiologies for the patient's clinical features is critical, even after beginning plasma exchange. The clinical basis for suspecting severe ADAMTS13 deficiency is described in the text. Exacerbations of TTP, either while continuing daily plasma exchange or after plasma exchange is stopped, and relapses rarely occur in patients without ADAMTS13 deficiency. Although rituximab may be appropriate for three different situations illustrated in this algorithm, we have never used more than a single course of rituximab for any patient. Definitions for response, exacerbation, remission, and relapse have been previously described.",
"    <sup>",
"     [1]",
"    </sup>",
"    Broken lines represent complications that occur in a minority of patients.",
"    <div class=\"footnotes\">",
"     PEX: plasma exchange; CVC: central venous catheter.",
"    </div>",
"    <div class=\"reference\">",
"     Reference:",
"     <br>",
"      <ol>",
"       <li>",
"        Vesely SK, George JN, L&auml;mmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003; 101(1):60-68.",
"       </li>",
"      </ol>",
"      <br>",
"       This research was originally published in Blood. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116:4060. Copyright &copy; 2010 American Society of Hematology.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5088=[""].join("\n");
var outline_f4_62_5088=null;
var title_f4_62_5089="Pathways of glycogen metabolism";
var content_f4_62_5089=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Metabolic pathways of glycogen metabolism and glycolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 600px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram shows the sites of enzymatic defects resulting in clinical glycogenoses. The glycogen storage disease types are as follows:",
"    <ul>",
"     <li>",
"      Type 0: Glycogen synthase deficiency",
"     </li>",
"     <li>",
"      Type Ia: Glucose 6-phosphatase (G6Pase) deficiency or von Gierke disease",
"     </li>",
"     <li>",
"      Type II: Acid maltase deficiency or Pompe disease",
"     </li>",
"     <li>",
"      Type III: Glycogen debrancher deficiency",
"     </li>",
"     <li>",
"      Type IV: Glycogen branching deficiency or Andersen disease",
"     </li>",
"     <li>",
"      Type V: Muscle phosphorylase deficiency or McArdle disease",
"     </li>",
"     <li>",
"      Type VI: Liver phosphorylase deficiency or Hers disease",
"     </li>",
"     <li>",
"      Type VII: Phosphofructokinase (PFK) deficiency or Tarui disease",
"     </li>",
"     <li>",
"      Type IX: Phosphorylase b kinase (PBK) deficiency",
"     </li>",
"     <li>",
"      Type X: Phosphoglycerate mutase (PGAM2) deficiency",
"     </li>",
"     <li>",
"      Type XI: Lactate dehydrogenase (LDH) deficiency",
"     </li>",
"     <li>",
"      Type XII: Aldolase A deficiency",
"     </li>",
"     <li>",
"      Type XIII: Beta-enolase deficiency",
"     </li>",
"     <li>",
"      Type XIV: Phosphoglucomutase-1 (PGM1) deficiency",
"     </li>",
"    </ul>",
"    Other deficiency syndromes, enzymes and intermediates include the following:",
"    <ul>",
"     <li>",
"      Fructose-1,6-bisphosphatase (F-1,6-BP) deficiency",
"     </li>",
"     <li>",
"      Glucokinase (GK)",
"     </li>",
"     <li>",
"      Glucose transporter 2 (GLUT2) deficiency or Fanconi-Bickel syndrome",
"     </li>",
"     <li>",
"      Phosphoglycerate kinase (PGK) deficiency",
"     </li>",
"     <li>",
"      Phosphophoenol pyruvate carboxykinase (PEPCK) deficiency",
"     </li>",
"     <li>",
"      Phosphorylase limit dextrin (PLD)",
"     </li>",
"     <li>",
"      Pyruvate carboxylase (PC) deficiency",
"     </li>",
"     <li>",
"      Pyruvate dehydrogenase (PDH)",
"     </li>",
"     <li>",
"      Pyruvate kinase (PK) deficiency",
"     </li>",
"     <li>",
"      Uridine diphosphoglucose (UDPG)",
"     </li>",
"     <li>",
"      Uridine diphosphoglucose pyrophosphorylase (UDPG-P)",
"     </li>",
"    </ul>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Griggs R, Mendell J, Miller R. Metabolic myopathies. In: Evaluation and Treatment of Myopathies, Griggs R, Mendell J, Miller R (Eds), FA Davis Co., Philadelphia 1995. p.247.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5089=[""].join("\n");
var outline_f4_62_5089=null;
var title_f4_62_5090="Diffuse cutaneous mastocytosis";
var content_f4_62_5090=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68182&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diffuse cutaneous mastocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Affected skin in a patient with diffuse cutaneous mastocytosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Soter, AN. J Invest Derm 1991; 96(3):S32. Copyright &copy; 1991 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5090=[""].join("\n");
var outline_f4_62_5090=null;
var title_f4_62_5091="MRI drug induced cardiomyopathy";
var content_f4_62_5091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 619px\">",
"   <div class=\"ttl\">",
"    Magnetic resonance imaging of hydroxychloroquine-induced cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 599px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance imaging (MRI) using black blood imaging in a 76-year-old female with longstanding rheumatoid arthritis treated with hydroxychloroquine (panel A) shows a thickened left ventricle (arrow) and a small pericardial effusion (arrowhead). The delayed T1 weighted sequence following gadolinium (panel B) shows mid-ventricular delayed enhancement (arrows). These findings are consistent with a nonischemic cardiomyopathy. Cardiac catheterization showed restrictive physiology.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5091=[""].join("\n");
var outline_f4_62_5091=null;
var title_f4_62_5092="EP study tracings RF ablation AVNRT";
var content_f4_62_5092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study showing identification of site for ablation of AV nodal reentrant tachycardia (AVNRT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shown are three surface ECG leads (I, aVF, V1) and intracardiac recordings from the high right atrium (HRA3-4); proximal (HBE3-4) and distal His bundle region (HBE1-2), which is obtained from the mapping catheter; proximal to distal coronary sinus (CS9-10, CS7-8, CS5-6, CS3-4, and CS1-2); and the right ventricular apex (RVA3-4). During sinus rhythm, the usual atrial (A) to ventricular (V) activiation sequence is seen. Application of radiofrequency (RF) energy to the tip of the HBE catheter (HBE1-2) promptly causes an accelerated junctional rhythm (*), further evidence of a good ablation site. Note that during the accelerated junctional rhythm, there is rapid 1:1 retrograde conduction to the atria (A), evidence that the fast AV nodal pathway is intact. Following this energy application, there was no evidence of slow pathway conduction and no inducible AVNRT.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5092=[""].join("\n");
var outline_f4_62_5092=null;
var title_f4_62_5093="Omega-3-acid ethyl esters (fish oil): Patient drug information";
var content_f4_62_5093=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Omega-3-acid ethyl esters (fish oil): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/46/21221?source=see_link\">",
"     see \"Omega-3-acid ethyl esters (fish oil): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F171381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lovaza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691358",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower triglycerides.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to omega-3-acid ethyl esters or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697830",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this product if you are allergic to fish.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4064662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have atrial fibrillation (Afib), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an inflamed pancreas, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697844",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stop using this product 14 days before dental care or surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12275 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-210.101.131.231-DF96EE1385-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5093=[""].join("\n");
var outline_f4_62_5093=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171381\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026170\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026169\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026174\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026175\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026177\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026172\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026173\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026178\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026179\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/46/21221?source=related_link\">",
"      Omega-3-acid ethyl esters (fish oil): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5094="Ibandronate: Patient drug information";
var content_f4_62_5094=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ibandronate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12423?source=see_link\">",
"     see \"Ibandronate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F181336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Boniva&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11442204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off or treat soft, brittle bones (osteoporosis).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Paget's disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ibandronate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705167",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tablet: If you are not able to stand or sit up for an hour.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: A swallowing tube (esophagus) that is not normal, low calcium levels, or trouble swallowing.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697156",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a swallowing tube (esophagus) that is not normal or trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone, joint, or muscle pain may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698193",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the jaw bone may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A broken leg may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Allergic side effects may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad jaw pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone, joint, or muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad groin or thigh pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698986",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699099",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Twitching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696101",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug works best when used with calcium/vitamin D and weight-bearing workouts like walking or PT (physical therapy).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach before breakfast.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695898",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water at least 60 minutes before the first food, drink, or drugs of the day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695915",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with plain water only. Avoid taking with mineral water or other drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694730",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not lie down for at least 60 minutes after taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695734",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 150 mg tablet on the same day each month.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696483",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take two 150 mg tablets within the same week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11495 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-C55D250E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5094=[""].join("\n");
var outline_f4_62_5094=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181336\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442204\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025089\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025088\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025093\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025094\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025096\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025091\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025092\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025097\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025098\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12423?source=related_link\">",
"      Ibandronate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5095="Large granular lymphocyte leukemia in rheumatoid arthritis";
var content_f4_62_5095=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Large granular lymphocyte leukemia in rheumatoid arthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5095/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5095/contributors\">",
"     Nancy Berliner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5095/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5095/contributors\">",
"     RN Maini, BA, MB BChir, FRCP, FMedSci, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5095/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5095/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/62/5095/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large granular lymphocyte (LGL) leukemia is characterized by a clonal proliferation of large granular lymphocytes (LGLs). LGLs comprise 5 percent of the population of peripheral blood mononuclear cells, are larger than most circulating lymphocytes, and have characteristic azurophilic granules containing acid hydrolases (",
"    <a class=\"graphic graphic_picture graphicRef69027 \" href=\"UTD.htm?0/1/28\">",
"     picture 1",
"    </a>",
"    ). They may be either T cells (T-LGL), the more common type, or natural killer (NK) cells (NK-LGL) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LGL leukemia is a heterogeneous disorder characterized by peripheral blood and marrow lymphocytic infiltration with LGLs, splenomegaly, and cytopenias, most commonly neutropenia. Up to one-third of patients with T-LGL leukemia also has rheumatoid arthritis (RA) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/2\">",
"     2",
"    </a>",
"    ]. LGL leukemia can also occur in association with Sj&ouml;gren&rsquo;s syndrome in the absence of RA [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/3\">",
"     3",
"    </a>",
"    ] and with other autoimmune disorders, including inflammatory bowel disease, systemic lupus, and autoimmune thyroid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, diagnosis, and differential diagnosis of LGL leukemia in the setting of rheumatoid arthritis are discussed here. Detailed discussions of T-LGL leukemia, NK-LGL leukemia, and their treatment are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=see_link\">",
"     \"Treatment of large granular lymphocyte leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=see_link\">",
"     \"Natural killer (NK) cell large granular lymphocyte leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4692188\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;T-LGL leukemia is very uncommon among patients with RA, despite the frequency of RA among patients with this disorder. In one study of over 1000 patients with RA, the prevalence of neutropenia that could not be attributed to other causes was 1.7 percent; one-third of the patients with neutropenia (0.6 percent of all patients with RA) exhibited large granular lymphocyte proliferation on bone marrow examination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mean age of onset of T-LGL leukemia in RA is 60 years, with no gender differences, which is similar to patients without arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458740684#H458740684\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504643\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;LGL leukemia associated with RA, like other LGL syndromes, is a clonal lymphoproliferative disease. It appears to represent one part of a spectrum of polyclonal and clonal disorders of LGL, including chronic large granular lymphocytosis, at least a subset of Felty&rsquo;s syndrome, and indolent or more aggressive leukemias [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In patients with rheumatologic disease, LGL leukemia is almost always the T-LGL type and tends to have a benign course [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The strong association of this disorder with autoimmune disease has led to the postulate that the clonal population may emerge from a polyclonal response to inciting antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/2\">",
"     2",
"    </a>",
"    ]. Interestingly, it has also been found that T-LGL leukemia is frequently associated with concomitant low-grade B-cell dyscrasias, suggesting the possibility of a common antigen that could drive both T and B cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. There is strong evidence that the proliferation of LGL also reflects a failure of Fas-mediated apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458750948#H458750948\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several factors appear to contribute to the neutropenia in the LGL syndrome, including defects in both proliferation and neutrophil survival [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/13\">",
"     13",
"    </a>",
"    ]. Fas-ligand (FasL), a member of the tumor necrosis factor family, is an important factor in the pathogenesis of neutropenia. FasL is expressed on the surface of activated cytotoxic T cells, and elevated levels of soluble FasL are found in the serum of most patients with LGL leukemia. Soluble FasL has been shown to increase apoptosis of neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. LGLs in the bone marrow may also inhibit myelopoiesis directly by local production of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/15\">",
"     15",
"    </a>",
"    ]. Antibody mediated mechanisms may also contribute to the neutropenia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/9,13\">",
"     9,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Next generation sequencing studies have identified activating somatic mutations in the signal transducer and activator of transcription 3 gene (STAT3) in LGL leukemia patients. Patients with STAT3 mutations were significantly more likely, compared with LGL leukemia patients without the mutations, to have rheumatoid arthritis and to exhibit neutropenia (26 verus 6 percent and 77 versus 50 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with T-LGL leukemia in the setting of rheumatoid arthritis (RA), the most common findings, by definition, are features of RA and the presence of LGL in increased numbers in the peripheral blood. Neutropenia is very common. The following features characterize these patients:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8861808\">",
"    <span class=\"h2\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rheumatoid arthritis (RA) often precedes the development of T-LGL leukemia, but both conditions may present concurrently [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"     6",
"    </a>",
"    ]. There is a broad range of severity of the arthritis, from mild, intermittent joint swelling to progressive, deforming arthropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6,17\">",
"     6,17",
"    </a>",
"    ]. Most patients have positive tests for rheumatoid factor and for anticyclic citrullinated peptide antibodies; these antibodies are also occasionally seen in patients with T-LGL leukemia without arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/7,17,18\">",
"     7,17,18",
"    </a>",
"    ]. Patients with concomitant RA and T-LGL leukemia also frequently have antinuclear antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8861815\">",
"    <span class=\"h2\">",
"     Hematologic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several hematologic findings are common, including neutropenia, lymphocytic bone marrow infiltration, lymphocytosis, anemia, splenomegaly, and thrombocytopenia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common presenting finding is neutropenia (about 85 percent); one-third of patients are asymptomatic and are diagnosed with neutropenia as an incidental finding [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/1\">",
"       1",
"      </a>",
"      ]. Neutropenia occurs in approximately 80 percent of patients with T-LGL leukemia overall; 40 to 45 percent develop severe neutropenia (absolute neutrophil count &lt;0.5 x",
"      <span class=\"nowrap\">",
"       10",
"       <sup>",
"        9",
"       </sup>",
"       /L)",
"      </span>",
"      with recurrent pyogenic infections [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/8,19\">",
"       8,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The bone marrow is infiltrated with lymphocytes in almost 90 percent of patients with LGL leukemia, three-fourths of whom have mild to moderate absolute lymphocytosis. Myeloid hypoplasia is noted in some patients and may correlate with the degree of cytotoxic T-lymphocyte infiltration [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anemia and thrombocytopenia are also common (50 and 20 percent, respectively).",
"     </li>",
"     <li>",
"      Splenomegaly is present in 20 to 50 percent of patients with T-LGL leukemia, and hepatomegaly occurs in 10 to 20 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8863556\">",
"    <span class=\"h2\">",
"     Other symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms other than those directly related to RA, when present, are usually related to neutropenia, including fever with recurrent bacterial infections in 20 to 40 percent of patients, although opportunistic infections are uncommon. Fatigue, fever, night sweats, or weight loss occurs in 20 to 30 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458740684#H458740684\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24860473\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of LGL leukemia is based upon the findings of elevated lymphocyte count and marrow infiltration with lymphocytes, a distinctive immunophenotype, and demonstration of clonality by molecular studies. LGLs in the setting of rheumatoid arthritis are typically CD3+, CD8+, and TCR-&alpha;&beta;+ T cells, although some may be CD4+, CD8-, and TCR&gamma;&delta;+ T cells. They also frequently express the mature T cell marker CD57 [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. Clonality can be confirmed by evaluating for monoclonal rearrangements of the T cell receptor by polymerase chain reaction or by Southern blotting [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/2\">",
"     2",
"    </a>",
"    ]. There is no absolute lymphocyte count or number of circulating LGL that is diagnostic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458740754#H458740754\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Pathologic features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458743514#H458743514\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with established rheumatoid arthritis who present with severe neutropenia, drug-induced cytopenia should be excluded, and flow cytometry and gene rearrangement studies should be performed on the peripheral blood. We obtain consultation with a hematologist for further evaluation, including bone marrow aspiration and biopsy, which are usually required to confirm the diagnosis and to exclude other causes of neutropenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8862195\">",
"    <span class=\"h2\">",
"     Relationship to Felty's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Felty&rsquo;s syndrome (FS), the triad of chronic arthritis, splenomegaly, and granulocytopenia, typically occurs in patients with severe, longstanding, seropositive RA, often in association with other extraarticular manifestations. Some of these patients have proliferation of LGL, and some patients previously diagnosed with FS would now be classified instead as having T-LGL leukemia, using current immunophenotyping techniques and molecular analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6,7,20\">",
"     6,7,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4247?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Felty's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The distinction between FS and T-LGL leukemia in patients with RA has generally been made based upon the determination of whether the LGL proliferation represents clonal expansion of cells, with those with polyclonality defined as having FS and with those with monoclonality as having LGL-leukemia. However, this distinction is not always clear. Small populations of clonally expanded T cells can be seen healthy individuals and in patients with RA and other chronic inflammatory conditions, suggesting that clonal expansion alone may not always define a population as malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6,7,21,22\">",
"     6,7,21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The observation that 85 to 90 percent of patients with both FS and RA-associated LGL leukemia are HLA-DR4 positive suggests a shared or very similar immunologic basis for these conditions and has supported the argument that they represent overlapping parts of a spectrum of conditions, rather than entirely distinct entities [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/2,23\">",
"     2,23",
"    </a>",
"    ]. However, patients with FS, compared with patients with LGL leukemia, are more likely to be identified late in their disease course and to be affected by severe RA and other extraarticular manifestations, including leg ulcers and rheumatoid nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/7\">",
"     7",
"    </a>",
"    ]. Only about 40 percent of patients with FS exhibit LGL proliferation. Additionally, patients with T-LGL leukemia without RA exhibit bone marrow features of a granulocytic proliferation defect, while patients with FS usually show features of a survival defect; however, mixed features may be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504836\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8862694\">",
"    <span class=\"h2\">",
"     Felty's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with RA, Felty&rsquo;s syndrome is the condition most likely to be confused with LGL leukemia and is sometimes considered to be part of a common spectrum. (See",
"    <a class=\"local\" href=\"#H8862195\">",
"     'Relationship to Felty's syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8862610\">",
"    <span class=\"h2\">",
"     Other LGL proliferative disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other conditions associated with LGL proliferation are not associated with RA, including NK cell LGL leukemia, an aggressive and difficult to treat syndrome which comprises about 5 percent of LGL disorders. This condition is diagnosed by immunophenotypic analysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=see_link\">",
"     \"Natural killer (NK) cell large granular lymphocyte leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reactive benign large granular lymphocytosis may occur in association with a number of viral syndromes and following splenectomy or bone marrow transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/7\">",
"     7",
"    </a>",
"    ]. These conditions can be distinguished from RA-associated T-LGL leukemia by their polyclonality and by the absence of RA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/12/3274?source=see_link&amp;anchor=H25#H25\">",
"     \"Approach to the patient with lymphocytosis or lymphocytopenia\", section on 'Lymphoproliferative disease of large granular lymphocytes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8862624\">",
"    <span class=\"h2\">",
"     T cell leukemias and lymphomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other conditions affecting T cells that are not associated with RA may also be considered in the differential diagnosis, including NK-like T cell lymphoma, hepatosplenic T cell lymphoma, post-transplant T cell lymphoproliferative disorders, S100 positive T cell lymphoproliferative disorders, and acute lymphoblastic leukemia. These are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458740775#H458740775\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4691492\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with T-LGL leukemia and RA usually have a chronic, indolent course with a median survival of over 10 years, although most eventually require therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/4,7,24\">",
"     4,7,24",
"    </a>",
"    ]. In the absence of infectious death, most patients survive for many years unless other problems intervene, although a small number of patients will succumb to progressive lymphoproliferative disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/1\">",
"     1",
"    </a>",
"    ]. Infection is the leading cause of death in this disorder. In contrast, patients with NK-LGL, which has not been associated with RA, typically have a more aggressive course [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5095/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=see_link&amp;anchor=H13#H13\">",
"     \"Natural killer (NK) cell large granular lymphocyte leukemia\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=see_link&amp;anchor=H20#H20\">",
"     \"Natural killer (NK) cell large granular lymphocyte leukemia\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24860672\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is indicated in symptomatic patients, including those with recurrent neutropenia-related infections, with other symptomatic cytopenias, or with transfusion dependence. The approach to asymptomatic patients, indications for treatment, and treatment of LGL leukemia in patients with rheumatoid arthritis are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=see_link&amp;anchor=H1147328340#H1147328340\">",
"     \"Treatment of large granular lymphocyte leukemia\", section on 'Indications for treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=see_link&amp;anchor=H1147328348#H1147328348\">",
"     \"Treatment of large granular lymphocyte leukemia\", section on 'Management of asymptomatic patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=see_link&amp;anchor=H30#H30\">",
"     \"Treatment of large granular lymphocyte leukemia\", section on 'Initial treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504828\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large granular lymphocyte (LGL) leukemia is characterized by peripheral blood and bone marrow lymphocytic infiltration with LGLs, splenomegaly, and cytopenias, most commonly neutropenia. Up to one-third of patients with LGL leukemia have rheumatoid arthritis (RA). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LGL leukemia associated with rheumatoid arthritis is a clonal lymphoproliferative disease. It appears to represent one part of a spectrum of polyclonal and clonal disorders of LGL, including at least a subset of patients with Felty&rsquo;s syndrome. In patients with rheumatologic disease, LGL leukemia is almost always the T-LGL type. (See",
"      <a class=\"local\" href=\"#H17504643\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RA often precedes the development of T-LGL leukemia, but both conditions may present concurrently. Most patients have positive tests for rheumatoid factor and anticyclic citrullinated peptide antibodies; many patients also have antinuclear antibodies. (See",
"      <a class=\"local\" href=\"#H8861815\">",
"       'Hematologic abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several factors appear to contribute to the neutropenia in the LGL syndrome, including defects in both proliferation and neutrophil survival. Patients also may exhibit anemia and thrombocytopenia. Splenomegaly may be present in up to half of patients and hepatomegaly in up to 20 percent. (See",
"      <a class=\"local\" href=\"#H17504643\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8861815\">",
"       'Hematologic abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One-third of patients are asymptomatic, other than from RA, but others experience fever, bacterial infections, fatigue, night sweats, or weight loss. (See",
"      <a class=\"local\" href=\"#H8863556\">",
"       'Other symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of LGL leukemia is based upon the findings of an elevated lymphocyte count and marrow infiltration with lymphocytes, a distinctive immunophenotype, and demonstration of clonality by molecular studies. LGLs in the setting of rheumatoid arthritis are typically CD3+, CD8+, and TCR-&alpha;&beta;+ T cells. Clonality can be confirmed by evaluating for monoclonal rearrangements of the T cell receptor by polymerase chain reaction or by Southern blotting. Clonality is the feature that is generally considered to distinguish this condition from Felty&rsquo;s syndrome associated with LGL, although these conditions are sometimes considered as parts of a single disease spectrum. (See",
"      <a class=\"local\" href=\"#H24860473\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8862195\">",
"       'Relationship to Felty's syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with RA-associated T-LGL leukemia usually have a chronic, indolent course with a median survival of over 10 years, although most eventually require therapy. (See",
"      <a class=\"local\" href=\"#H4691492\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53011939\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editors of UpToDate, Inc. would like to acknowledge Robert S Pinals, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/1\">",
"      Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/2\">",
"      Wlodarski MW, Schade AE, Maciejewski JP. T-large granular lymphocyte leukemia: current molecular concepts. Hematology 2006; 11:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/3\">",
"      Friedman J, Schattner A, Shvidel L, Berrebi A. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Semin Arthritis Rheum 2006; 35:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/4\">",
"      Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/5\">",
"      Saway PA, Prasthofer EF, Barton JC. Prevalence of granular lymphocyte proliferation in patients with rheumatoid arthritis and neutropenia. Am J Med 1989; 86:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/6\">",
"      Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006; 20:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/7\">",
"      Shah A, Diehl LF, St Clair EW. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia. Clin Immunol 2009; 132:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/8\">",
"      Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist 2006; 11:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/9\">",
"      Viny AD, Lichtin A, Pohlman B, et al. Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 2008; 49:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/10\">",
"      Pawarode A, Baer M. T/B and not T/B: high frequency of B-cell dyscrasias in T-LGL leukemia. Leuk Lymphoma 2008; 49:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/11\">",
"      Shah MV, Zhang R, Loughran TP Jr. Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma 2009; 9 Suppl 3:S244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/12\">",
"      Yang J, Epling-Burnette PK, Painter JS, et al. Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 2008; 111:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/13\">",
"      Mohan SR, Maciejewski JP. Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia. Curr Opin Hematol 2009; 16:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/14\">",
"      Liu JH, Wei S, Lamy T, et al. Chronic neutropenia mediated by fas ligand. Blood 2000; 95:3219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/15\">",
"      Coakley G, Iqbal M, Brooks D, et al. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum 2000; 43:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/16\">",
"      Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/17\">",
"      Prochorec-Sobieszek M, Rymkiewicz G, Makuch-asica H, et al. Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Res Ther 2008; 10:R55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/18\">",
"      Barton JC, Prasthofer EF, Egan ML, et al. Rheumatoid arthritis associated with expanded populations of granular lymphocytes. Ann Intern Med 1986; 104:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/19\">",
"      Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol 2003; 40:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/20\">",
"      Snowden N, Bhavnani M, Swinson DR, et al. Large granular T lymphocytes, neutropenia and polyarthropathy: an underdiagnosed syndrome? Q J Med 1991; 78:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/21\">",
"      Fitzgerald JE, Ricalton NS, Meyer AC, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995; 154:3538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/22\">",
"      Hingorani R, Monteiro J, Furie R, et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. J Immunol 1996; 156:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/23\">",
"      Starkebaum G, Loughran TP Jr, Gaur LK, et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997; 40:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5095/abstract/24\">",
"      Dhodapkar MV, Li CY, Lust JA, et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84:1620.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7489 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-46FA143880-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5095=[""].join("\n");
var outline_f4_62_5095=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17504828\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4692188\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17504643\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8861808\">",
"      Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8861815\">",
"      Hematologic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8863556\">",
"      Other symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24860473\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8862195\">",
"      Relationship to Felty's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17504836\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8862694\">",
"      Felty's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8862610\">",
"      Other LGL proliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8862624\">",
"      T cell leukemias and lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4691492\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24860672\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17504828\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H53011939\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7489\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7489|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/1/28\" title=\"picture 1\">",
"      Large granular lymphocytes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/12/3274?source=related_link\">",
"      Approach to the patient with lymphocytosis or lymphocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4247?source=related_link\">",
"      Clinical manifestations and diagnosis of Felty's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=related_link\">",
"      Natural killer (NK) cell large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=related_link\">",
"      Treatment of large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5096="Evaluation of diffuse lung disease by conventional chest radiography";
var content_f4_62_5096=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of diffuse lung disease by conventional chest radiography",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5096/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/62/5096/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pulmonologist and radiologist commonly recognize a variety of abnormal patterns of diffuse parenchymal lung disease on the conventional chest radiograph. Identification of these patterns, along with recognition of other associated findings, can be extremely useful in guiding the development of a differential diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/1\">",
"     1",
"    </a>",
"    ]. The diagnostic approach to diffuse lung disease based on interpretation of the conventional chest radiograph will be discussed here, using examples to illustrate many of the radiographic features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CRITIQUE OF PATTERN USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The traditional approach to radiographic assessment of diffuse lung disease first involves determining whether the pulmonary parenchymal process is located within the interstitium or the alveolar spaces. However, although radiographic criteria for both types of processes have been established over the years, the correlation is relatively poor between the accuracy of the radiologic localization (to either the airspaces or the interstitium) and the actual pathologic findings. Specific issues include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nodular patterns can be produced by either interstitial or alveolar disease.",
"     </li>",
"     <li>",
"      Interstitial pneumonias usually also involve the alveolar compartment.",
"     </li>",
"     <li>",
"      So-called alveolar disease regularly involves the interstitium as well. The paradigm of pure alveolar disease is pulmonary alveolar proteinosis, yet high resolution computed tomographic (HRCT) scanning has shown that, even in this entity, the interlobular and intralobular septa are thickened, forming the &ldquo;crazy paving&rdquo; pattern on thin-section CT.",
"     </li>",
"     <li>",
"      Air bronchograms, the ultimate radiographic sign of air space disease, can be detected in a small percentage of cases of histologically pure or predominant interstitial lung disease, such as sarcoidosis, pulmonary lymphoma, and pulmonary calcinosis.",
"     </li>",
"     <li>",
"      Ground glass opacities are formed by either alveolar or interstitial disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of these limitations, a more descriptive approach has been promulgated by radiologists. This approach takes into account an analysis of predominant opacities, an analysis of lung volumes, distribution of disease, and the presence of associated findings [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef54536 \" href=\"UTD.htm?27/30/28139\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An attempt to avoid the usage of histologic terminology was made by the International Labor Office (ILO) in graphically describing the radiographic findings of pneumoconioses. The ILO classification system uses standard chest radiographs, graphic rather than anatomic descriptors, and a semiquantitative scheme for profusion of opacities (based on a 12-point scale) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/5\">",
"     5",
"    </a>",
"    ]. This scheme has an acceptable interobserver variability.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small opacities are classified based upon shape (round, irregular, or a combination thereof) and size",
"     </li>",
"     <li>",
"      Round (ie, nodular) opacities are characterized as p (up to 1.5 mm) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75561 \" href=\"UTD.htm?35/39/36470\">",
"       image 1",
"      </a>",
"      ), q (1.5 to 3 mm) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68302 \" href=\"UTD.htm?9/18/9510\">",
"       image 2",
"      </a>",
"      ), and r (3 to 10 mm) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67606 \" href=\"UTD.htm?40/10/41126\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Irregular (ie, linear, reticular) opacities are labeled as s (up to 1.5 mm) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82072 \" href=\"UTD.htm?22/20/22854\">",
"       image 4",
"      </a>",
"      ), t (1.5 to 3 mm) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61246 \" href=\"UTD.htm?7/14/7399\">",
"       image 5",
"      </a>",
"      ), and u (3 to 10 mm)",
"     </li>",
"     <li>",
"      The profusion of these opacities is assessed, as well as their distribution in the upper, middle, or lower lung zones",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In practical terms, the predominant small opacity is best identified on the frontal chest radiograph in areas of low profusion and on the lateral chest radiograph in the retrosternal clear space and over the cardiac silhouette.",
"   </p>",
"   <p>",
"    This classification, or at least basic elements of it, can also be utilized for description of diffuse lung diseases other than the pneumoconioses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Large opacities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ILO classification also makes provision for describing large opacities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72316 \" href=\"UTD.htm?25/61/26582\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52306 \" href=\"UTD.htm?18/38/19046\">",
"     image 7",
"    </a>",
"    ). The application of this principle to pulmonary consolidation avoids pseudo-histologic nomenclature that does not correspond to the actual findings or is misleading, eg, airspace disease, alveolar disease, or infiltrate. The terms consolidation, parenchymal disease, or parenchymal opacification are more graphic and descriptive, allowing for creation of a differential diagnosis without implying a particular histology.",
"   </p>",
"   <p>",
"    Large opacities can be described as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diffuse homogeneous",
"     </li>",
"     <li>",
"      Multifocal patchy (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59037 \" href=\"UTD.htm?11/37/11861\">",
"       image 8",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lobar without atelectasis",
"     </li>",
"     <li>",
"      Lobar with atelectasis",
"     </li>",
"     <li>",
"      Perihilar",
"     </li>",
"     <li>",
"      Peripheral (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef86465 \" href=\"UTD.htm?21/20/21831\">",
"       image 9",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These six patterns cover the majority of consolidative lung parenchymal abnormalities. These terms should be used rather than the word \"infiltrate,\" which often has an associated diagnostic connotation, ie, suggesting pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     BASIC PATTERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main radiological patterns often used to describe diffuse lung disease are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nodular (including micronodular and miliary)",
"     </li>",
"     <li>",
"      Reticular (fine or ground glass, medium or irregular, coarse or honeycomb) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60208 \" href=\"UTD.htm?26/8/26758\">",
"       image 10",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Linear (septal or Kerley's)",
"     </li>",
"     <li>",
"      Reticular and nodular",
"     </li>",
"     <li>",
"      Destructive",
"     </li>",
"     <li>",
"      Alveolar",
"     </li>",
"     <li>",
"      Bronchial",
"     </li>",
"     <li>",
"      Arterial",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Micronodular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micronodules correspond to the p opacities of the ILO classification and have a diameter smaller than 1.5 mm. They are seen only infrequently and are caused by a small number of diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alveolar microlithiasis, a rare disorder characterized by the intraalveolar accumulation of lamellated calcospherites in the absence of abnormal systemic calcium homeostasis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79692 \" href=\"UTD.htm?28/37/29269\">",
"       image 11",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Intravenous talc injection (in drug abusers), with subsequent talc granulomatosis",
"     </li>",
"     <li>",
"      Embolization of Ethiodol (after bipedal lymphangiography)",
"     </li>",
"     <li>",
"      Early stages of pneumoconioses such as silicosis, coal worker's pneumoconiosis, inhalational talcosis (not to be confused with hematogenous talc granulomatosis), and beryllium disease",
"     </li>",
"     <li>",
"      Subacinar foci in air space disease, eg, early stages of pulmonary alveolar proteinosis or Pneumocystis jirovecii pneumonia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"       \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Nodular",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nodular pattern includes nodules up to 1 cm in diameter (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50429 \" href=\"UTD.htm?16/55/17270\">",
"     image 12",
"    </a>",
"    ). Causes include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious or inflammatory granulomata (eg, miliary tuberculosis, sarcoidosis, fungal diseases, hypersensitivity pneumonitis [extrinsic allergic alveolitis], eosinophilic granuloma [Langerhans cell histiocytosis], cytomegalovirus pneumonia and, occasionally, influenza, varicella, or respiratory syncytial virus pneumonia) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef57178 \" href=\"UTD.htm?3/8/3207\">",
"       image 13",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pneumoconioses (eg, silicosis, coal worker's pneumoconiosis, talcosis, and beryllium-induced disease) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75722 \" href=\"UTD.htm?5/3/5175\">",
"       image 14",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79172 \" href=\"UTD.htm?30/57/31638\">",
"       image 15",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Neoplasia (eg, bronchioloalveolar cell carcinoma [in-situ adenocarcinoma], metastatic carcinoma, and lymphoma) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66519 \" href=\"UTD.htm?9/49/10006\">",
"       image 16",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pulmonary hemosiderosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nodular disease becomes visible through a summation effect unless the nodules are larger than 5 mm, their profusion is very low, or the nodules are displayed free of superimposition on HRCT. Nodular disease can also appear as a combined reticular and nodular pattern on the chest radiograph.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Linear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Linear opacities are mostly due to thickened interlobular septa. Kerley, a British radiologist, first described these lines in coal worker's pneumoconiosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Kerley's A lines radiate from the hilum into the lung periphery preferentially towards the upper lobes. They represent thickening of the axial pulmonary interstitium. They appear frequently in acute left ventricular failure or in pulmonary edema due to altered capillary permeability (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63891 \" href=\"UTD.htm?36/43/37558\">",
"       image 17",
"      </a>",
"      ). These lines have a length of 2 to 4 cm.",
"     </li>",
"     <li>",
"      Kerley's B lines result from thickening of the subpleural interstitium. They are about 1 cm in length, 1 mm in thickness, and have a predilection for the lower lung zones abutting a pleural surface. These lines are particularly well seen in chronic left ventricular failure, mitral valve disease, lymphangitic carcinomatosis, and asbestosis. Kerley&rsquo;s B lines can be observed in viral pneumonia, particularly with Hantavirus, Coronavirus (SARS), and measles pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Kerley's C lines are due to thickening of the lung parenchymal interstitium and can yield a reticular rather than a linear pattern on chest radiography.",
"     </li>",
"     <li>",
"      Occasionally, the wall of subpleural emphysematous spaces due to paraseptal emphysema can form linear opacities that resemble Kerley's B line, but are longer and extend more cephalad. Infectious or respiratory bronchiolitis (RBILD) can produce linear shadows that do not quite abut the pleura.",
"     </li>",
"     <li>",
"      Thickening of bronchial walls or bronchiectases can result in a linear pattern on chest radiographs, but with a more central, perihilar distribution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Reticular",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reticular pattern corresponds to the small irregular opacities in the ILO classification (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82072 \" href=\"UTD.htm?22/20/22854\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61246 \" href=\"UTD.htm?7/14/7399\">",
"     image 5",
"    </a>",
"    ). The differential diagnosis is based upon the acuteness or the chronicity of the process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Acute diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute diseases which produce a reticular pattern include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interstitial edema due to left ventricular failure (so-called Kerley's C lines)",
"     </li>",
"     <li>",
"      Acute viral or mycoplasma pneumonia",
"     </li>",
"     <li>",
"      Acute pneumonia in collagen vascular disease, particularly systemic lupus erythematosus (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58248 \" href=\"UTD.htm?10/26/10662\">",
"       image 18",
"      </a>",
"      ) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"       \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Acute allergic reactions, eg, transfusion reactions (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63891 \" href=\"UTD.htm?36/43/37558\">",
"       image 17",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Chronic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic reticular changes are generally due to:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic interstitial pneumonias (primarily idiopathic pulmonary fibrosis",
"      <span class=\"nowrap\">",
"       [IPF]/usual",
"      </span>",
"      interstitial pneumonia [UIP], but also desquamative interstitial pneumonia [DIP], lymphocytic interstitial pneumonia [LIP], and occasionally cryptogenic organizing pneumonia",
"      <span class=\"nowrap\">",
"       [COP]/bronchiolitis",
"      </span>",
"      obliterans with organizing pneumonia [BOOP]) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/7\">",
"       7",
"      </a>",
"      ]&nbsp;(",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76204 \" href=\"UTD.htm?28/34/29222\">",
"       image 19",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55168 \" href=\"UTD.htm?30/33/31253\">",
"       image 20",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Collagen vascular diseases (eg, scleroderma, rheumatoid lung) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61363 \" href=\"UTD.htm?21/29/21973\">",
"       image 21",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78807 \" href=\"UTD.htm?23/12/23748\">",
"       image 22",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Asbestosis",
"     </li>",
"     <li>",
"      Radiation pneumonia",
"     </li>",
"     <li>",
"      End-stage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)",
"     </li>",
"     <li>",
"      Drug reactions",
"     </li>",
"     <li>",
"      Lymphangitic spread of tumor (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60655 \" href=\"UTD.htm?1/61/2005\">",
"       image 23",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67941 \" href=\"UTD.htm?24/26/24997\">",
"       image 24",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      End-stage granulomatous infections",
"     </li>",
"     <li>",
"      End-stage eosinophilic granuloma (ie, Langerhans cell histiocytosis)",
"     </li>",
"     <li>",
"      Lymphangioleiomyomatosis",
"     </li>",
"     <li>",
"      Sarcoidosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56653 \" href=\"UTD.htm?13/4/13381\">",
"       image 25",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      LIP",
"     </li>",
"     <li>",
"      Lymphoma &ndash; bronchovascular form",
"     </li>",
"     <li>",
"      Kaposi's sarcoma &ndash; bronchovascular form",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The distribution of chronic reticular changes can also provide clues to the underlying diagnosis. These patterns include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic interstitial pneumonias, asbestosis, drug reactions, and collagen vascular disease have a predilection for the periphery of the lung. Sarcoid, lymphoma, and Kaposi's sarcoma tend to progress from the perihilar lung into the periphery.",
"     </li>",
"     <li>",
"      Lymphangioleiomyomatosis, eosinophilic granuloma (ie, Langerhans cell histiocytosis), granulomatous infections, and lymphangitic spread of tumor have a diffuse distribution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reticular and linear changes can mimic combined reticulonodular pathology at the point of intersection of lines. This is called the moir&eacute; effect, defined as a visual perception that results from superimposition of a repetitive design and yields a pattern distinctive from its original components.",
"   </p>",
"   <p>",
"    Honeycombing is a feature of endstage interstitial lung disease. It represents restructuring of the lung parenchyma, with simplification of the lung architecture and subsequent bronchiolectasis. The small subpleural spaces, which usually measure between 3 and 10 mm in diameter, connect with the airway and therefore collapse on expiratory imaging. The expiratory collapse of these spaces distinguishes them from the subpleural spaces of paraseptal emphysema, which do not decrease their size with expiration. In addition, honeycombs have slightly thicker walls than emphysematous spaces. Honeycombing forms an array of multilayered spaces, while paraseptal emphysematous spaces are single- layered (ie, single-tiered).",
"   </p>",
"   <p>",
"    Honeycombing is regularly seen in patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       IPF/UIP",
"      </span>",
"     </li>",
"     <li>",
"      Other interstitial pneumonias",
"     </li>",
"     <li>",
"      Eosinophilic granuloma (ie, Langerhans cell histiocytosis)",
"     </li>",
"     <li>",
"      Collagen vascular diseases",
"     </li>",
"     <li>",
"      Previous necrotizing infections",
"     </li>",
"     <li>",
"      Pneumoconiosis",
"     </li>",
"     <li>",
"      Endstage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Destructive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small lungs, diffuse consolidation, bronchiolectasis and honeycombing, bullae, cysts, coarse linear scarring, retraction of hilar structures cranially, and pulmonary arterial hypertension are all part of the spectrum of destructive lung disease. This type of endstage lung disease can be found as a consequence of diffuse alveolar damage or as the final endpoint in interstitial pneumonias and granulomatous processes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Alveolar",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic features of alveolar or air space disease include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airspace (ie, acinar) nodules, 0.6 to 1 cm in diameter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef70236 \" href=\"UTD.htm?2/0/2054\">",
"       image 26",
"      </a>",
"      ). These nodules do not represent an acinus in the strict anatomic sense, since they are encompassing peribronchiolar lung tissue.",
"     </li>",
"     <li>",
"      Ground-glass opacification in the early stages of the process (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61559 \" href=\"UTD.htm?24/0/24580\">",
"       image 27",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Coalescent opacities (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58394 \" href=\"UTD.htm?5/36/5701\">",
"       image 28",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62269 \" href=\"UTD.htm?9/10/9379\">",
"       image 29",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Consolidation that tends to follow lobar or segmental boundaries (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81172 \" href=\"UTD.htm?14/3/14390\">",
"       image 30",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef76321 \" href=\"UTD.htm?3/13/3286\">",
"       image 31",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Consolidation with a bronchocentric distribution.",
"     </li>",
"     <li>",
"      Air bronchograms (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81172 \" href=\"UTD.htm?14/3/14390\">",
"       image 30",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Air alveolograms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, these radiographic features do not guarantee the exclusive histologic presence of alveolar filling, but they are helpful in attempting to place a disease into a particular radiological category.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bronchial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse bronchiectasis represents the classic example of a bronchial pattern. On conventional chest radiographs, linear opacities and lucencies are visible, conforming to the course of bronchi (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55878 \" href=\"UTD.htm?32/31/33270\">",
"     image 32",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72062 \" href=\"UTD.htm?3/54/3942\">",
"     image 33",
"    </a>",
"    ). Mucoid impaction, seen in asthmatics or in patients with allergic bronchopulmonary aspergillosis, produces variable appearances, including abnormalities that are described as V-shaped, Y-shaped, toothpaste shadows, \"cluster of grapes\" opacities, or \"finger in glove\" opacities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62091 \" href=\"UTD.htm?1/60/1989\">",
"     image 34",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cystic spaces are prevalent in saccular bronchiectasis, with occasional gas-liquid levels. The \"dirty lungs\" pattern seen in smokers with chronic bronchitis is likely due to peribronchial fibrosis and bronchial wall thickening, with accompanying mild cylindrical bronchiectasis and pulmonary arterial hypertension. Bronchiectases have a central, perihilar predilection as they extend into the more peripheral lung.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Arterial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several patterns of pulmonary blood flow can be distinguished on conventional chest radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Caudalisation is the normal flow pattern, with basal vessels being two to three times wider than apical vessels.",
"     </li>",
"     <li>",
"      Cephalization occurs with left ventricular failure (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58231 \" href=\"UTD.htm?43/39/44661\">",
"       image 35",
"      </a>",
"      ), mitral valve stenosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74462 \" href=\"UTD.htm?39/53/40789\">",
"       image 36",
"      </a>",
"      ), basal emphysema (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65594 \" href=\"UTD.htm?39/47/40693\">",
"       image 37",
"      </a>",
"      ), or recumbent patients. The upper lobe vessels are more dilated than the basal vessels.",
"     </li>",
"     <li>",
"      Equalization or balanced flow with hyperemia is seen in hyperkinetic circulation due to left-to-right shunts, hyperthyroidism (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82599 \" href=\"UTD.htm?24/9/24724\">",
"       image 38",
"      </a>",
"      ), pregnancy, or anemia. Equalization implies that the upper and lower lobe pulmonary vessels are similar in size.",
"     </li>",
"     <li>",
"      Equalization or balanced flow with oligemia occurs in hypovolemia or right-to-left shunts (eg, Tetralogy of Fallot).",
"     </li>",
"     <li>",
"      Centralization, which reflects dilatation of central pulmonary vessels with a concurrently normal or diminished peripheral circulation, is seen in pulmonary arterial hypertension (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62807 \" href=\"UTD.htm?39/31/40436\">",
"       image 39",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56714 \" href=\"UTD.htm?40/38/41571\">",
"       image 40",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Lateralization of flow to one lung over the other, ie, asymmetric perfusion, is seen with unilateral emphysema or unilateral obstruction of the pulmonary artery (",
"      <a class=\"graphic graphic_picture graphicRef70102 \" href=\"UTD.htm?27/0/27653\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Localization of flow or a mosaic pattern of perfusion is seen with patchy emphysema, chronic thromboembolic pulmonary arterial hypertension (CTEPH), bronchiolitis obliterans, or arteriovenous malformations (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54915 graphicRef66676 \" href=\"UTD.htm?17/20/17737\">",
"       image 41A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Collateralization is seen with bronchial or other systemic arterial supply to the lungs, resulting in a lattice-like pattern of vessels. It is seen with severe tetralogy of Fallot or in proximal interruption of the pulmonary artery (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66743 \" href=\"UTD.htm?39/19/40244\">",
"       image 42",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     LUNG VOLUMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A frequent feature of chronic diffuse infiltrative lung disease is loss of lung volume. Occasionally, low lung volumes can represent the first manifestation of such a process.",
"   </p>",
"   <p>",
"    However, some of the chronic diffuse infiltrative lung diseases are associated with normal or large lung volumes, often as a result of airflow obstruction or cystic changes that accompany the disease. Examples of chronic diffuse infiltrative lung disease that can be associated with normal or large lung volumes include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Eosinophilic granuloma (ie, Langerhans cell histiocytosis).",
"     </li>",
"     <li>",
"      Sarcoidosis (preserved lung volumes) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56653 \" href=\"UTD.htm?13/4/13381\">",
"       image 25",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lymphangioleiomyomatosis (hyperexpanded lungs).",
"     </li>",
"     <li>",
"      Cystic fibrosis (hyperexpanded lungs). It should be noted that cystic fibrosis is primarily a form of airways disease rather than infiltrative disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DISEASE DISTRIBUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic distribution of lung disease can greatly facilitate the approach to differential diagnosis.",
"   </p>",
"   <p>",
"    Upper zone lung disease is found preferentially in:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tuberculosis",
"     </li>",
"     <li>",
"      Fungal disease",
"     </li>",
"     <li>",
"      Sarcoidosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80390 \" href=\"UTD.htm?4/15/4342\">",
"       image 43",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pneumoconiosis (with the notable exception of asbestosis) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79172 \" href=\"UTD.htm?30/57/31638\">",
"       image 15",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Eosinophilic granuloma (ie, Langerhans cell histiocytosis)",
"     </li>",
"     <li>",
"      Ankylosing spondylitis",
"     </li>",
"     <li>",
"      Cystic fibrosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55878 \" href=\"UTD.htm?32/31/33270\">",
"       image 32",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cystic Pneumocystis jirovecii pneumonia",
"     </li>",
"     <li>",
"      Radiation fibrosis",
"     </li>",
"     <li>",
"      Endstage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Basal lung disease is found in a different group of diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bronchiectasis",
"     </li>",
"     <li>",
"      Aspiration",
"     </li>",
"     <li>",
"      DIP",
"     </li>",
"     <li>",
"      Nonspecific interstitial pneumonia and fibrosis",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       IPF/UIP",
"      </span>",
"     </li>",
"     <li>",
"      Drug reactions",
"     </li>",
"     <li>",
"      Asbestosis",
"     </li>",
"     <li>",
"      Scleroderma",
"     </li>",
"     <li>",
"      Rheumatoid arthritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Central, perihilar lung disease occurs in:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sarcoidosis",
"     </li>",
"     <li>",
"      Lymphoma",
"     </li>",
"     <li>",
"      Kaposi's sarcoma",
"     </li>",
"     <li>",
"      Bronchiectases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Peripheral lung disease is found in:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       COP/BOOP,",
"      </span>",
"      <span class=\"nowrap\">",
"       IPF/UIP,",
"      </span>",
"      DIP",
"     </li>",
"     <li>",
"      Asbestosis",
"     </li>",
"     <li>",
"      Eosinophilic lung disease",
"     </li>",
"     <li>",
"      Graft-versus-host disease",
"     </li>",
"     <li>",
"      Rare cases of pseudoalveolar sarcoidosis",
"     </li>",
"     <li>",
"      Rare cases of bronchioloalveolar carcinoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These patterns of distribution are often quite useful, but any infiltrative lung process in the advanced stages can involve both lungs diffusely [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5096/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ASSOCIATED FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Associated radiographic findings related to the pleura, hila, mediastinum, bronchi, heart, and pulmonary vasculature can provide diagnostic clues in the setting of diffuse parenchymal lung disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pleural disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural disease occasionally accompanies diffuse lung disease and can help narrow the differential diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pneumothorax is classically described in eosinophilic granuloma (ie, Langerhans cell histiocytosis) of the lung, but it is also a relatively common complication of advanced interstitial lung disease of any etiology. The highest frequency of pneumothoraces is described in lymphangioleiomyomatosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/30/4586?source=see_link\">",
"       \"Pulmonary lymphangioleiomyomatosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pleural effusions are seen in patients with metastatic malignancy (including lymphangitic carcinomatosis), collagen vascular diseases (especially systemic lupus erythematosus and rheumatoid arthritis), lymphangioleiomyomatosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56652 \" href=\"UTD.htm?27/48/28421\">",
"       image 44",
"      </a>",
"      ), and occasionally as a complication of asbestos exposure. The entity of benign asbestos pleural effusion has no relationship to pleural plaques and occurs much earlier following exposure to the asbestos fibers.",
"     </li>",
"     <li>",
"      Pleural plaques are characteristically seen in longstanding asbestos exposure. They accompany the lung fibrosis of asbestosis in 30 to 50 percent of cases.",
"     </li>",
"     <li>",
"      Focal pleural thickening is on occasion seen as a sequela of amyloidosis involving the lungs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Lymph node enlargement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse lung disease can be accompanied by enlarged intrathoracic lymph nodes, visible either on chest radiographs or on CT scans. The following diseases can be associated with diffuse pulmonary disease and enlarged intrathoracic lymph nodes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sarcoidosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78632 \" href=\"UTD.htm?2/4/2118\">",
"       image 45",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lymphoma",
"     </li>",
"     <li>",
"      Tuberculosis",
"     </li>",
"     <li>",
"      Fungal diseases",
"     </li>",
"     <li>",
"      Pneumoconioses (especially silicosis, coal-worker&rsquo;s pneumoconiosis, and beryllium disease)",
"     </li>",
"     <li>",
"      Bronchogenic carcinoma",
"     </li>",
"     <li>",
"      Metastatic malignancy other than bronchogenic carcinoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cor pulmonale",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right ventricular hypertrophy subsequent to pulmonary arterial hypertension is found in a high percentage of patients with end-stage diffuse lung disease. Obliteration of small peripheral pulmonary artery branches in combination with hypoxic vasoconstriction leads to pulmonary arterial hypertension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=see_link\">",
"     \"Cor pulmonale\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     NORMAL RADIOGRAPHS IN SYMPTOMATIC PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In about 10 percent of patients with biopsy-proven diffuse interstitial lung disease, the chest radiograph is initially normal, even though the patient is dyspneic, may have decreased exercise tolerance, or has a decreased diffusion capacity of carbon monoxide (DLCO). The best examples are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      DIP",
"     </li>",
"     <li>",
"      Sarcoidosis",
"     </li>",
"     <li>",
"      Hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)",
"     </li>",
"     <li>",
"      Pneumocystis pneumonia in HIV-infected patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In such situations, high resolution CT scanning (HRCT) can add information and detect subtle ground-glass opacities not suspected on conventional radiographs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pattern recognition on a conventional chest radiograph is an important first step in the evaluation of patients with diffuse lung disease, although a multitude of diseases can produce the same pattern. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Critique of pattern use'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A graphic description is preferable to use of histologic terminology. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The main radiological patterns used to describe diffuse lung disease are as follows: Nodular (including micronodular and miliary), reticular (fine or ground glass, medium or irregular, coarse or honeycomb), linear (septal or Kerley's), reticular and nodular, destructive, alveolar, bronchial, and arterial. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Basic patterns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional aspects of lung disease that may be characterized by conventional chest radiography are the lung volumes, disease distribution, and associated findings. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Lung volumes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Disease distribution'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Associated findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HRCT is a very helpful tool to supplement the information from conventional chest radiography. It can refine the differential diagnostic considerations and has improved sensitivity and specificity over conventional chest radiography, particularly in complex cases. In some situations, such as in idiopathic pulmonary fibrosis, HRCT can be definitive and obviate the need for a biopsy. However, in a majority of cases, biopsy is needed for definitive diagnosis, particularly if treatment depends on a specific diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"       \"High resolution computed tomography of the lungs\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/1\">",
"      Felson B. A new look at pattern recognition of diffuse pulmonary disease. AJR Am J Roentgenol 1979; 133:183.",
"     </a>",
"    </li>",
"    <li>",
"     Genereux GP. Radiologic assessment of diffuse lung disease. In: Radiology, Diagnosis, Imaging, Intervention, Taveras, Ferrucci (Eds), JP Lippincott, Philadelphia 1992. Vol 1, p.1-18.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/3\">",
"      McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology 1983; 149:353.",
"     </a>",
"    </li>",
"    <li>",
"     McLoud TC. Chronic infiltrative lung disorders. In: Radiology, Diagnosis, Imaging, Intervention, Taveras, Ferrucci (Eds), JP Lippincott, Philadelphia 1992. Vol 1, p.1-17.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/5\">",
"      Russell, A (Ed). International Labour Office: Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconioses. Revised Edition 1980. Medical Radiography and Photography 1981; 1:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/6\">",
"      Franquet T. Imaging of pulmonary viral pneumonia. Radiology 2011; 260:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/7\">",
"      Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics 2007; 27:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/8\">",
"      Ravin CE. Pulmonary vascularity: radiographic considerations. J Thorac Imaging 1988; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5096/abstract/9\">",
"      M&uuml;ller NL, Coiby TV. Idiopathic interstitial pneumonias: high-resolution CT and histologic findings. Radiographics 1997; 17:1016.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6979 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-629A639819-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5096=[""].join("\n");
var outline_f4_62_5096=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CRITIQUE OF PATTERN USE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Large opacities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BASIC PATTERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Micronodular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Nodular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Linear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Reticular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Acute diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Chronic diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Destructive",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Alveolar",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bronchial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Arterial",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      LUNG VOLUMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DISEASE DISTRIBUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ASSOCIATED FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pleural disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Lymph node enlargement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      NORMAL RADIOGRAPHS IN SYMPTOMATIC PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6979\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6979|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/39/36470\" title=\"diagnostic image 1\">",
"      Micronodules PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/18/9510\" title=\"diagnostic image 2\">",
"      Miliary nodules PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/10/41126\" title=\"diagnostic image 3\">",
"      Small nodules PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/20/22854\" title=\"diagnostic image 4\">",
"      Reticular opacities PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/14/7399\" title=\"diagnostic image 5\">",
"      Reticular opacities PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/61/26582\" title=\"diagnostic image 6\">",
"      Conglomerate shadows PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/38/19046\" title=\"diagnostic image 7\">",
"      Conglomerate shadows PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/37/11861\" title=\"diagnostic image 8\">",
"      Septic embolization PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/20/21831\" title=\"diagnostic image 9\">",
"      Chronic eosinophilic pneumonia CXR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/8/26758\" title=\"diagnostic image 10\">",
"      Arc welders lung PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/37/29269\" title=\"diagnostic image 11\">",
"      Alveolar microlithiasis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/55/17270\" title=\"diagnostic image 12\">",
"      Healed varicella pneumonia PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/8/3207\" title=\"diagnostic image 13\">",
"      Miliary tuberculosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/3/5175\" title=\"diagnostic image 14\">",
"      Coal workers pneumoconiosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/57/31638\" title=\"diagnostic image 15\">",
"      Silicosis CXR PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/49/10006\" title=\"diagnostic image 16\">",
"      Bronchogenic spread PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/43/37558\" title=\"diagnostic image 17\">",
"      Kerleys A lines PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/26/10662\" title=\"diagnostic image 18\">",
"      SLE with pneumonitis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/34/29222\" title=\"diagnostic image 19\">",
"      Idiopathic pulm fibrosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/33/31253\" title=\"diagnostic image 20\">",
"      Idiopathic pulm fibrosis PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/29/21973\" title=\"diagnostic image 21\">",
"      Endstage scleroderma lung PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/12/23748\" title=\"diagnostic image 22\">",
"      SLE pulmonary fibrosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/61/2005\" title=\"diagnostic image 23\">",
"      Multiple ring shadows PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/26/24997\" title=\"diagnostic image 24\">",
"      Unilateral lung cancer PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/4/13381\" title=\"diagnostic image 25\">",
"      Stage III sarcoidosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/0/2054\" title=\"diagnostic image 26\">",
"      Acute varicella pneumonia PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/0/24580\" title=\"diagnostic image 27\">",
"      PCP in AIDS PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/36/5701\" title=\"diagnostic image 28\">",
"      Pulmonary edema PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/10/9379\" title=\"diagnostic image 29\">",
"      Alveolar proteinosis chest xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/3/14390\" title=\"diagnostic image 30\">",
"      Alveolar cell carcinoma PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/13/3286\" title=\"diagnostic image 31\">",
"      Non Hodgkins lymphoma PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/31/33270\" title=\"diagnostic image 32\">",
"      Adult cystic fibrosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/54/3942\" title=\"diagnostic image 33\">",
"      Mounier Kuhn syndrome PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/60/1989\" title=\"diagnostic image 34\">",
"      Bronchopulm aspergillosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/39/44661\" title=\"diagnostic image 35\">",
"      Interstitial edema PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/53/40789\" title=\"diagnostic image 36\">",
"      Mitral valve disease PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/47/40693\" title=\"diagnostic image 37\">",
"      Panacinar emphysema PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/9/24724\" title=\"diagnostic image 38\">",
"      Pulmonary plethora PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/31/40436\" title=\"diagnostic image 39\">",
"      Pulmonary hypertension PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/38/41571\" title=\"diagnostic image 40\">",
"      Eisenmengers PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/33/18964\" title=\"diagnostic image 41A\">",
"      Chronic PE PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/60/7109\" title=\"diagnostic image 41B\">",
"      Chronic PE PA I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/19/40244\" title=\"diagnostic image 42\">",
"      Fallots tetralogy PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/15/4342\" title=\"diagnostic image 43\">",
"      Endstage sarcoidosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/48/28421\" title=\"diagnostic image 44\">",
"      Lymphangioleiomyomatosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/4/2118\" title=\"diagnostic image 45\">",
"      Sarcoidosis stage II PA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6979|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/0/27653\" title=\"picture 1\">",
"      Massive unilateral edema PA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6979|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/30/28139\" title=\"table 1\">",
"      Diffuse lung disease diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=related_link\">",
"      Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=related_link\">",
"      Cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/30/4586?source=related_link\">",
"      Pulmonary lymphangioleiomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5097="Unipolar depression in adults: Treatment with surgical approaches";
var content_f4_62_5097=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Unipolar depression in adults: Treatment with surgical approaches",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5097/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5097/contributors\">",
"     Paul E Holtzheimer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5097/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5097/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5097/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5097/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/62/5097/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H9580630\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unipolar major depression often does not respond to standard treatment with pharmacotherapy, psychotherapy, and noninvasive neuromodulation interventions such as electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS). This has led to investigation of invasive treatments that include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgical implantation of devices",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vagus nerve stimulation (VNS)",
"     </li>",
"     <li>",
"      Deep brain stimulation",
"     </li>",
"     <li>",
"      Direct cortical stimulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ablative neurosurgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic reviews treatment of refractory unipolar major depression with vagus nerve stimulation, deep brain stimulation, direct cortical stimulation, and ablative neurosurgery. Overviews of neuromodulation procedures, electroconvulsive therapy, transcranial magnetic stimulation, and treating refractory depression are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/30/6633?source=see_link\">",
"       \"Unipolar depression in adults: Overview of neuromodulation procedures\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41305?source=see_link\">",
"       \"Overview of electroconvulsive therapy (ECT) for adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16682?source=see_link\">",
"       \"Unipolar depression in adults: Treatment with transcranial magnetic stimulation (TMS)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=see_link\">",
"       \"Treatment of resistant depression in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1161777\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical interventions are reserved for patients with unipolar major depression who are refractory to multiple courses of treatment, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Monotherapy with different classes of antidepressants",
"     </li>",
"     <li>",
"      Sequential trials of an antidepressant plus an augmentation agent (eg, second-generation antipsychotic,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      , or triiodothyronine)",
"     </li>",
"     <li>",
"      Psychotherapy (eg, cognitive-behavioral therapy or interpersonal psychotherapy) added onto pharmacotherapy",
"     </li>",
"     <li>",
"      At least one course of noninvasive neuromodulation that usually consists of electroconvulsive therapy (ECT), but may also include transcranial magnetic stimulation (TMS)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among invasive treatments for unipolar major depression, ablative neurosurgery is the &ldquo;last resort&rdquo; and its use is heavily restricted; independent review boards are generally involved to ensure that all standard treatments have failed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most studies of surgical neurostimulation interventions have maintained patients on their presurgical antidepressant medications and psychotherapies after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86962738\">",
"    <span class=\"h2\">",
"     Assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidates for surgical treatment of refractory unipolar major depression should be evaluated to confirm the diagnosis and whether surgery can be performed safely. The assessment includes a psychiatric history and mental status examination, with emphasis upon current depressive (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 1",
"    </a>",
"    ) and psychotic symptoms, comorbid disorders (eg, substance use and personality disorders), neuropsychological functioning, length of the current depressive episode, types and number of failed treatments during the present episode, psychosocial functioning, and ability to provide informed consent, as well as the number, length, and treatment history of prior depressive episodes.",
"   </p>",
"   <p>",
"    In addition, a general medical history and physical examination is performed, as well as laboratory tests and neuroimaging studies that are guided by the history, examination, and possibility of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The medical work-up should emphasize preexisting neurologic disease (eg, epilepsy, intracranial masses, and vascular abnormalities).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580637\">",
"    <span class=\"h1\">",
"     VAGUS NERVE STIMULATION (VNS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vagus nerve stimulation (VNS) is a clinically available intervention that involves surgery (typically with general anesthesia) to attach an electrode around one vagus nerve (usually the left because of its limited cardiac effects) in the carotid sheath; the electrode is connected to a pulse generator implanted subcutaneously in the chest wall [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. The device is turned on after a post-surgical recovery period generally lasting two weeks. Stimulation is intermittent and parameters (eg, current, pulse width, and frequency) are adjusted using a hand held transmitter. Vagus nerve stimulation is an established treatment for medication-refractory epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/9\">",
"     9",
"    </a>",
"    ], which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19578?source=see_link\">",
"     \"Vagus nerve stimulation therapy for the treatment of epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580644\">",
"    <span class=\"h2\">",
"     Outcome studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no rigorous data that indicate vagus nerve stimulation is efficacious for treatment resistant unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/10\">",
"     10",
"    </a>",
"    ]. Although open-label studies suggest that the intervention may perhaps be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4,11,12\">",
"     4,11,12",
"    </a>",
"    ], a randomized trial found no benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/13\">",
"     13",
"    </a>",
"    ]. The 10 week trial compared vagus nerve stimulation with sham stimulation (no stimulation following implantation) in 222 patients with treatment resistant major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/13\">",
"     13",
"    </a>",
"    ]. Response (improvement from baseline on the depression rating scale &ge;50 percent) was comparable for active and sham treatment (15 and 10 percent).",
"   </p>",
"   <p>",
"    The benefit of vagus nerve stimulation for treatment resistant depression may possibly accrue over time, based upon open label studies that followed patients for up to one or two years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4,14-17\">",
"     4,14-17",
"    </a>",
"    ]. As an example, a one year, prospective, observational study found that response occurred significantly more often in 180 patients with treatment resistant major depression who received vagus nerve stimulation plus treatment as usual, compared to 112 comparable patients followed in a separate study who received treatment as usual alone (22 versus 12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/12\">",
"     12",
"    </a>",
"    ]. However, many patients who responded subsequently relapsed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580651\">",
"    <span class=\"h2\">",
"     Safety and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vagus nerve stimulation is generally safe and well-tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/18\">",
"     18",
"    </a>",
"    ]. Risks include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Bleeding",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"     <li>",
"      Anesthesia complications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stimulation (usually occurs for a 30 second period every 5 minutes) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4,13\">",
"       4,13",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Voice",
"      <span class=\"nowrap\">",
"       alteration/hoarseness",
"      </span>",
"      (by far the most common adverse effect)",
"     </li>",
"     <li>",
"      Cough",
"     </li>",
"     <li>",
"      Dyspnea",
"     </li>",
"     <li>",
"      Dysphagia",
"     </li>",
"     <li>",
"      Neck pain",
"     </li>",
"     <li>",
"      Paresthesia",
"     </li>",
"     <li>",
"      Vomiting",
"     </li>",
"     <li>",
"      Laryngismus",
"     </li>",
"     <li>",
"      Dyspepsia",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Hypomania or mania",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stimulation-related side effects can generally be minimized by reducing the stimulation intensity [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4\">",
"     4",
"    </a>",
"    ]. No significant adverse neuropsychologic effects of chronic vagus nerve stimulation for treatment resistant depression have been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/19\">",
"     19",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Other serious events have occurred in studies of vagus nerve stimulation for treatment resistant depression. In a 10 week randomized trial (N = 222) that compared active with sham stimulation, one patient treated with active stimulation committed suicide; the investigators attributed the death to the underlying mood disorder rather than the treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/13\">",
"     13",
"    </a>",
"    ]. In addition, one case of asystole and one case of bradycardia occurred during surgery in the active stimulation group. In a two year observational study of vagus nerve stimulation (N = 74), two suicides and one brain hemorrhage secondary to a suicide attempt occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Batteries for the pulse generator (implanted subcutaneously in the chest) need to be replaced periodically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580665\">",
"    <span class=\"h2\">",
"     Mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of action by which vagus nerve stimulation may perhaps treat unipolar major depression is unknown. The vagus nerve (cranial nerve X) is a mixed nerve composed of about 80 percent afferent sensory fibers carrying information to the brain and 20 percent efferent fibers sending signals from the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/20\">",
"     20",
"    </a>",
"    ]. The nerve is connected to the nucleus solitarius, which communicates with brain stem nuclei implicated in mood regulation (eg, the locus coeruleus). In addition, neuroimaging data suggest that vagus nerve stimulation can alter activity in several cortical and subcortical brain regions that may be involved in mood regulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H671842\">",
"    <span class=\"h2\">",
"     Outside sources of patient education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Educational material explaining vagus nerve stimulation for patients and family members is freely available for printing at the United States",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/\">",
"     National Institute of Mental Health",
"    </a>",
"    website.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580672\">",
"    <span class=\"h1\">",
"     DEEP BRAIN STIMULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep brain stimulation (DBS) is an investigational treatment for intractable unipolar major depression, in which one or more electrodes are implanted into targeted brain regions through burr holes or a craniotomy using a stereotactic frame and magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Surgery is usually performed under local anesthesia with the patient awake [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4,26\">",
"     4,26",
"    </a>",
"    ]. A second procedure is performed under general anesthesia to tunnel wires beneath the scalp and skin of the neck to connect the electrodes to a pulse generator that controls stimulation parameters and is implanted subcutaneously in the chest. Stimulation is usually continuous rather than intermittent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/4\">",
"     4",
"    </a>",
"    ], and parameters (eg, voltage, pulse-width, and frequency) are adjusted with a handheld transmitter [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/24,26\">",
"     24,26",
"    </a>",
"    ]. In the United States, deep brain stimulation is available to patients with unipolar major depression only through a research protocol.",
"   </p>",
"   <p>",
"    It is not known if the efficacy of deep brain stimulation for treatment refractory depression varies according to which brain region is stimulated or if different subtypes of depression respond to stimulation of different regions. Regions targeted for stimulation include the [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/27,28\">",
"     27,28",
"    </a>",
"    ] :",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Subcallosal cingulate gyrus",
"     </li>",
"     <li>",
"      Ventral anterior internal capsule and ventral striatum",
"     </li>",
"     <li>",
"      Nucleus accumbens",
"     </li>",
"     <li>",
"      Inferior thalamic peduncle",
"     </li>",
"     <li>",
"      Habenula &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Electrical stimulation of deep brain centers is an established treatment for refractory Parkinson disease, essential tremor, and dystonia, and an investigational treatment for obsessive-compulsive disorder (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32105?source=see_link&amp;anchor=H5#H5\">",
"     \"Surgical treatment of Parkinson disease\", section on 'Deep brain stimulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28741?source=see_link&amp;anchor=H6#H6\">",
"     \"Surgical treatment of essential tremor\", section on 'Deep brain stimulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of dystonia\", section on 'Deep brain stimulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30678?source=see_link\">",
"     \"Deep brain stimulation for treatment of obsessive-compulsive disorder\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580679\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of deep brain stimulation for treatment refractory major depression has been evaluated in prospective observational studies that targeted different neuroanatomical sites; response (improvement from baseline on the depression rating scale &ge; 50 percent) occurred in approximately 30 to 60 percent of patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Subcallosal cingulate gyrus",
"      </strong>",
"      &ndash; In a study of subcallosal cingulate white matter stimulation in 20 patients, response occurred within one month in 35 percent, after one year in 55 percent, and after three to six years in 55 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. Employment increased from 10 to 50 percent of patients within one year.",
"      <br/>",
"      <br/>",
"      In a study of subcallosal cingulate stimulation in 17 patients, response occurred within six months in 41 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3\">",
"       3",
"      </a>",
"      ]. Among 12 patients treated for two years, 92 percent responded.",
"      <br/>",
"      <br/>",
"      In a 12 month study of subcallosal cingulate stimulation in 21 patients, response occurred in 29 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/31\">",
"       31",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <strong>",
"       Ventral anterior internal capsule and ventral striatum",
"      </strong>",
"      &ndash; In a study of ventral anterior internal capsule and ventral striatum stimulation in 15 patients, response occurred after 3 months in 47 percent, and after 6 to 51 months in 53 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <strong>",
"       Nucleus accumbens",
"      </strong>",
"      &ndash; A one year study of nucleus accumbens stimulation in 10 patients found that response occurred in 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, one patient with refractory major depression remitted after inferior thalamic peduncle stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/34\">",
"     34",
"    </a>",
"    ], and another patient after habenula stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/35\">",
"     35",
"    </a>",
"    ]. A third case report described a patient who initially remitted with ablative cingulotomy, relapsed, and then remitted with cingulate gyrus stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although response in open label studies of major depression may be due to placebo effects, this seems less likely in deep brain stimulation studies, given the chronic course of illness and large number of treatments that had previously failed. As an example, one deep brain stimulation study stipulated that the presenting depressive episode had lasted at least two years and had not responded to antidepressants from at least three different classes, nor to at least two trials of an antidepressant plus an adjunctive drug (eg, second-generation antipsychotic or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    ), at least one course of electroconvulsive therapy, and a trial of psychotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/32\">",
"     32",
"    </a>",
"    ]. A review found that placebo responses in unipolar major depression occur less often in episodes that are more persistent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/37\">",
"     37",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In addition, responses to deep brain stimulation that are sustained for years in patients with refractory depression are inconsistent with placebo responses, especially when battery failure or planned discontinuation of stimulation unbeknownst to patients is associated with relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3,30,32\">",
"     3,30,32",
"    </a>",
"    ]. Response to stimulation typically progresses over time, whereas a placebo response is generally marked by a large initial effect that subsequently decays [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/29\">",
"     29",
"    </a>",
"    ]. That said, placebo responses have been observed in randomized trials that compared surgical interventions with placebo for treatment of other neuropsychiatric conditions. As an example, a pooled analysis found that among 36 patients with Parkinson disease who received placebo in trials of surgical treatments, response (improvement from baseline on the symptom rating scale &ge; 50 percent) occurred in 15 (42 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Response to deep brain stimulation probably depends upon stimulation parameters and the activity state of the stimulated site [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/24\">",
"     24",
"    </a>",
"    ]. Optimal stimulation parameters are not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580686\">",
"    <span class=\"h2\">",
"     Safety and adverse side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serious risks of deep brain stimulation include those associated with surgery, such as intracranial bleeding (which can cause permanent neurologic deficits), infection, and anesthesia complications (including death) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/25\">",
"     25",
"    </a>",
"    ]; however, these risks appear to be low [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/26,39\">",
"     26,39",
"    </a>",
"    ]. More commonly, hardware may malfunction, wires fracture, and electrodes dislodge. In addition, batteries for the pulse generator (implanted subcutaneously in the chest) need to be replaced periodically, and the pulse generator may be inadvertently deactivated by magnetic fields (eg, metal detectors).",
"   </p>",
"   <p>",
"    Another safety issue is that attempted and completed suicides have occurred in four studies of deep brain stimulation that targeted different neuroanatomical sites [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3,30,31,33\">",
"     3,30,31,33",
"    </a>",
"    ]. Although it is possible that the intervention was responsible, it seems more likely that suicidality in these patients reflects their severity of illness and need for close monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/40\">",
"     40",
"    </a>",
"    ]. As an example, one study included four patients who remitted with deep brain stimulation; two subsequently attempted suicide and two others committed suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/30\">",
"     30",
"    </a>",
"    ]. Three of the patients had attempted suicide prior to surgery, and two had a family history of completed suicide. One patient who killed herself had four maternal relatives who committed suicide; following remission with deep brain stimulation, the patient relapsed and was then successfully treated with electroconvulsive therapy three months before death.",
"   </p>",
"   <p>",
"    Open label studies of deep brain stimulation for treatment refractory depression found that side effects included [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3,26,28,29,31-33\">",
"     3,26,28,29,31-33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Agitation",
"     </li>",
"     <li>",
"      Dysphoria",
"     </li>",
"     <li>",
"      Hypomania",
"     </li>",
"     <li>",
"      Psychosis",
"     </li>",
"     <li>",
"      Diaphoresis",
"     </li>",
"     <li>",
"      Diarrhea",
"     </li>",
"     <li>",
"      Disequilibrium",
"     </li>",
"     <li>",
"      Dizziness",
"     </li>",
"     <li>",
"      Dysphagia",
"     </li>",
"     <li>",
"      Headache",
"     </li>",
"     <li>",
"      Insomnia",
"     </li>",
"     <li>",
"      Muscle cramps, spasms, and stiffness",
"     </li>",
"     <li>",
"      Nausea and vomiting",
"     </li>",
"     <li>",
"      Pain at incision site",
"     </li>",
"     <li>",
"      Paraesthesia",
"     </li>",
"     <li>",
"      Polyuria",
"     </li>",
"     <li>",
"      Seizure",
"     </li>",
"     <li>",
"      Swollen eye",
"     </li>",
"     <li>",
"      Syncope",
"     </li>",
"     <li>",
"      Tinnitus",
"     </li>",
"     <li>",
"      Tremor",
"     </li>",
"     <li>",
"      Weight gain",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adverse effects of stimulation may be specific to stimulation location and parameters, and are generally transient or resolve after adjusting stimulus parameters. &nbsp;",
"   </p>",
"   <p>",
"    Neuropsychological functioning does not appear to be adversely affected by deep brain stimulation, based upon prospective, open label studies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A one year study of subcallosal cingulate stimulation in six patients found that attention, executive functioning, memory, psychomotor speed, risk",
"      <span class=\"nowrap\">",
"       taking/decision",
"      </span>",
"      making, and verbal intelligence quotient did not deteriorate, and that performance improved in several areas that were impaired at baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A one year study of nucleus accumbens stimulation, and a comparable study of ventral anterior internal capsule and ventral striatum stimulation, each with 10 patients, found no detrimental effects upon executive functioning, general intellectual ability, language, learning, memory, and processing speed [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A six month study of subcallosal cingulate stimulation in 17 patients found that general intellectual ability, executive functioning, memory, risk",
"      <span class=\"nowrap\">",
"       taking/decision",
"      </span>",
"      making, and set shifting remained stable or improved [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580700\">",
"    <span class=\"h2\">",
"     Therapeutic mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of action by which deep brain stimulation may treat unipolar major depression is unknown. Based upon biochemical, postmortem, and functional and structural neuroimaging studies, the most likely hypothesis is that stimulation modulates pathologic activity within a network (circuit) of integrated grey matter brain regions that are involved in mood regulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/28,29,33,42,43\">",
"     28,29,33,42,43",
"    </a>",
"    ]. The neuronal effects of modulation depend upon the location and mix of cell bodies and white matter fibers in the field of stimulation, and whether the neurons are excitatory, inhibitory, or modulatory [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172385327\">",
"    <span class=\"h2\">",
"     Outside sources of patient education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Educational material explaining deep brain stimulation for patients and family members is freely available for printing at the United States",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/\">",
"     National Institute of Mental Health",
"    </a>",
"    website.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580707\">",
"    <span class=\"h1\">",
"     DIRECT CORTICAL STIMULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct cortical stimulation (also called epidural cortical stimulation) is an investigational treatment for refractory unipolar major depression, in which one or more epidural or subdural electrodes are implanted through burr holes or a craniotomy to directly stimulate a targeted area of the cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The electrodes are connected by leads that run beneath the scalp and skin of the neck to a pulse generator, which controls stimulation parameters and is implanted subcutaneously in the chest. In the United States, direct cortical stimulation is available to patients with unipolar major depression only through a research protocol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580714\">",
"    <span class=\"h2\">",
"     Effectiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of refractory unipolar major depression with direct cortical stimulation has been evaluated in the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A two month, single-blind, randomized trial compared direct cortical stimulation (targeting the left dorsolateral frontal cortex) with sham treatment in 11 patients who were masked to treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/45\">",
"       45",
"      </a>",
"      ]. Improvement of symptoms did not differ significantly between the two groups. Following the randomized phase, the 11 patients received open label, active treatment for two years, and response (improvement from baseline on the depression rating scale &ge; 50 percent) occurred in 5 patients within 1 to 15 months. &nbsp;",
"     </li>",
"     <li>",
"      In a seven month, open label observational study that implanted epidural electrodes bilaterally at the anterior frontal poles and midlateral prefrontal cortex in five patients, remission occurred in three patients within four to seven months [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/44\">",
"       44",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580721\">",
"    <span class=\"h2\">",
"     Safety and adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risks of direct cortical stimulation are primarily related to the nonspecific risks of surgery (bleeding, infection, and anesthesia complications), and the pulse generator needs to be replaced periodically. Studies have reported urinary incontinence and worsening of essential tremor, but have not observed seizures, episodes of mania or psychosis, or worsening cognition [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580735\">",
"    <span class=\"h2\">",
"     Mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of action by which direct cortical stimulation may treat unipolar major depression is unknown; one hypothesis is that the procedure modulates activity within a network of grey matter brain regions that are involved in mood regulation and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580742\">",
"    <span class=\"h1\">",
"     ABLATIVE NEUROSURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ablative neurosurgery for intractable unipolar major depression is a clinically available but rarely used approach in which a lesion is made in limbic or paralimbic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1\">",
"     1",
"    </a>",
"    ]. Early ablative techniques for psychiatric illness, such as the prefrontal leucotomy (&ldquo;lobotomy&rdquo;) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/47\">",
"     47",
"    </a>",
"    ], were initially used in the 1950&rsquo;s prior to the discovery of the first antidepressant medications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. However, stereotactic neurosurgical techniques that allow for more focal lesions with fewer side effects have emerged and include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/51-54\">",
"     51-54",
"    </a>",
"    ] :",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterior capsulotomy &ndash; Lesion in the anterior limb of the internal capsule that connects the frontal cortex and thalamus",
"     </li>",
"     <li>",
"      Anterior cingulotomy &ndash; Bilateral lesions in the dorsal anterior cingulate gyrus",
"     </li>",
"     <li>",
"      Subcaudate tractotomy &ndash; Bilateral lesions in thalamocortical white matter tracts inferior to the anterior striatum",
"     </li>",
"     <li>",
"      Limbic leucotomy &ndash; Combines cingulotomy with subcaudate tractotomy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Craniotomy is typically used to perform these procedures, although a gamma knife can be used for capsulotomy because of its particularly small lesion volume [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cingulotomy has been used most often, with over 500 reported cases [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/36\">",
"     36",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H322069\">",
"    <span class=\"h2\">",
"     Indication",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no established criteria (including number and type of failed treatments) that need to be met before a patient with unipolar major depression is considered appropriate for ablative surgery; this largely depends upon the clinical judgment of the evaluating psychiatrist and neurosurgeon. Candidates include patients with chronic, severe, and incapacitating symptoms that are refractory to [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,2,56,57\">",
"     1,2,56,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pharmacotherapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Monotherapy with several (eg, four) different antidepressant classes at therapeutic doses for several weeks (eg, four to eight)",
"     </li>",
"     <li>",
"      Multiple (eg, three) trials of an antidepressant plus an established adjunctive drug (eg, second-generation antipsychotic,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      , and triiodothyronine)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adjunctive psychotherapy such as cognitive-behavioral therapy or interpersonal psychotherapy",
"     </li>",
"     <li>",
"      Electroconvulsive therapy (ECT)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contraindications to ablative surgery for unipolar major depression include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,56,57\">",
"     1,56,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severe personality disorders",
"     </li>",
"     <li>",
"      Comorbid substance use disorders",
"     </li>",
"     <li>",
"      Suicidal ideation or behavior",
"     </li>",
"     <li>",
"      Chronic, poorly controlled general medical conditions",
"     </li>",
"     <li>",
"      Previously diagnosed intracranial masses",
"     </li>",
"     <li>",
"      Intracerebral vascular abnormalities",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Institutions offering ablative neurosurgery for treatment refractory depression often have a multidisciplinary committee to review referrals and ensure that the procedure is indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In many countries, use of the procedure is controlled by legislation and overseen by public agencies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/2,51,56\">",
"     2,51,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Before undertaking ablative neurosurgery, clinicians and patients with major depression should note that the course of illness is such that recovery can occur after lengthy periods of illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/19/38201?source=see_link&amp;anchor=H858471#H858471\">",
"     \"Unipolar depression in adults: Prognosis and course of illness\", section on 'Chronic major depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580749\">",
"    <span class=\"h2\">",
"     Response",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials for ablative procedures in treatment refractory depression. Based upon prospective observational studies, response (improvement from baseline on the depression rating scale &ge; 50 percent) occurs in approximately 30 to 60 percent of patients; the evidence includes a study of: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      33 patients treated with anterior cingulotomy or limbic leucotomy (mean duration of follow-up 30 months); response occurred in 33 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      8 patients treated with anterior cingulotomy (duration of follow-up 12 months); response occurred in 63 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/57\">",
"       57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      20 patients treated with anterior capsulotomy (mean duration of follow-up 7 years); response occurred in 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/2\">",
"       2",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a retrospective study, 23 patients treated for major depression with subcaudate tractotomy or limbic leucotomy were interviewed, with a mean duration of follow-up of 14 years; recovery occurred in 22 percent and significant improvement in 48 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/56\">",
"     56",
"    </a>",
"    ]. However, 29 other patients were alive and lost to follow-up, and among 24 patients who were deceased at follow-up, 25 percent had committed suicide.",
"   </p>",
"   <p>",
"    Improvement of major depression with ablative surgery generally occurs within days to weeks of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/56\">",
"     56",
"    </a>",
"    ], but the effect may be delayed for months [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,58\">",
"     1,58",
"    </a>",
"    ]. Insufficient or impersistent improvement may lead patients to undergo a second operation to extend the lesions created in the first operation or to make lesions in an additional site [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,2,56\">",
"     1,2,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580756\">",
"    <span class=\"h2\">",
"     Risks and side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with treatment refractory depression, observational studies suggest that ablative surgery is associated with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonspecific neurosurgical risks [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,56\">",
"       1,56",
"      </a>",
"      ]: &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Intracranial bleeding",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"     <li>",
"      Anesthesia complications",
"     </li>",
"     <li>",
"      Delirium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risks specific to the lesion [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,2,19,56\">",
"       1,2,19,56",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Epilepsy",
"     </li>",
"     <li>",
"      Impaired cognition (including executive functioning, memory, set shifting, and verbal fluency)",
"     </li>",
"     <li>",
"      Personality changes (eg, impulsivity, disinhibition, and amotivation)",
"     </li>",
"     <li>",
"      Weight gain",
"     </li>",
"     <li>",
"      Urinary incontinence (typically transient)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, some studies found that neurosurgery did not adversely affect neuropsychological function [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/2,57\">",
"     2,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9580770\">",
"    <span class=\"h2\">",
"     Mechanism of action",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for using ablative procedures is based upon a model that conceptualizes refractory major depression as a problem in neural networks (circuits) that regulate mood, rather than an abnormality in a single neuroanatomical structure or neurotransmitter system [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5097/abstract/1,46\">",
"     1,46",
"    </a>",
"    ]. It is hypothesized that abnormal communication between grey matter brain regions involved in the pathophysiology of major depression can be interrupted by severing their white matter connections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86073853\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unipolar major depression often does not respond to standard treatment, which has led to investigation and use of invasive (surgical) treatments that include vagus nerve stimulation (VNS), deep brain stimulation, direct cortical stimulation, and ablative neurosurgery. (See",
"      <a class=\"local\" href=\"#H9580630\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical interventions are reserved for patients with major depression who are refractory to multiple courses of pharmacotherapy, psychotherapy, and noninvasive neuromodulation interventions (eg, electroconvulsive therapy and transcranial magnetic stimulation). (See",
"      <a class=\"local\" href=\"#H1161777\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The assessment of candidates for surgical treatment of refractory major depression includes a psychiatric history and mental status examination, with emphasis upon current depressive (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"       table 1",
"      </a>",
"      ) and psychotic symptoms, comorbid disorders, neuropsychological functioning, length of the current depressive episode, types and number of failed treatments, psychosocial functioning, and ability to provide informed consent. A general medical history, physical examination, and focused laboratory tests and neuroimaging studies are also performed, with emphasis upon preexisting neurologic disease. (See",
"      <a class=\"local\" href=\"#H86962738\">",
"       'Assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vagus nerve stimulation is a clinically available intervention that involves surgery to attach an electrode around one vagus nerve; the electrode is connected by a wire to a pulse generator implanted subcutaneously in the chest wall. Although open-label studies suggest that the intervention may perhaps be effective, a randomized trial found no benefit. The most common side effect is voice alteration. (See",
"      <a class=\"local\" href=\"#H9580637\">",
"       'Vagus nerve stimulation (VNS)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Deep brain stimulation is an investigational treatment in which electrodes are implanted into targeted brain regions through burr holes using a stereotactic frame and magnetic resonance imaging. A second procedure is performed to tunnel wires beneath the skin to connect the electrodes to a pulse generator that controls stimulation parameters and is implanted subcutaneously in the chest. (See",
"      <a class=\"local\" href=\"#H9580672\">",
"       'Deep brain stimulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Direct cortical stimulation is an investigational treatment in which epidural or subdural electrodes are implanted through burr holes to directly stimulate a targeted area of the cortex. The electrodes are connected by leads that run beneath the skin to a pulse generator, which controls stimulation parameters and is implanted subcutaneously in the chest. (See",
"      <a class=\"local\" href=\"#H9580707\">",
"       'Direct cortical stimulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ablative neurosurgery for intractable major depression is a clinically available but rarely used approach in which a lesion is made in limbic or paralimbic structures. The first ablative procedures that were developed have been supplanted by stereotactic neurosurgical techniques that allow for more focal lesions with fewer side effects. (See",
"      <a class=\"local\" href=\"#H9580742\">",
"       'Ablative neurosurgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/1\">",
"      Shields DC, Asaad W, Eskandar EN, et al. Prospective assessment of stereotactic ablative surgery for intractable major depression. Biol Psychiatry 2008; 64:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/2\">",
"      Christmas D, Eljamel MS, Butler S, et al. Long term outcome of thermal anterior capsulotomy for chronic, treatment refractory depression. J Neurol Neurosurg Psychiatry 2011; 82:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/3\">",
"      Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012; 69:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/4\">",
"      Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord 2009; 117 Suppl 1:S44.",
"     </a>",
"    </li>",
"    <li>",
"     Freudenreich O, Nejad SH, Francis A, Fricchione GL. Psychosis, mania, and catatonia. In: Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL.  (Ed), American Psychiatric Publishing, Washington, DC 2011. p.219.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/6\">",
"      Work Group on Psychiatric Evaluation, American Psychiatric Association Steering Committee on Practice Guidlines. Psychiatric evaluation of adults. Second edition. American Psychiatric Association. Am J Psychiatry 2006; 163:3.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition, 2006. file://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on July 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/8\">",
"      Marangell LB, Martinez M, Jurdi RA, Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand 2007; 116:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/9\">",
"      Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002; 1:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/10\">",
"      Shuchman M. Approving the vagus-nerve stimulator for depression. N Engl J Med 2007; 356:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/11\">",
"      Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005; 58:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/12\">",
"      George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005; 58:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/13\">",
"      Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/14\">",
"      Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008; 38:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/15\">",
"      Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005; 66:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/16\">",
"      Sackeim HA, Brannan SK, Rush AJ, et al. Durability of antidepressant response to vagus nerve stimulation (VNS). Int J Neuropsychopharmacol 2007; 10:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/17\">",
"      Bajbouj M, Merkl A, Schlaepfer TE, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 2010; 30:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/18\">",
"      Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/19\">",
"      Moreines JL, McClintock SM, Holtzheimer PE. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul 2011; 4:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/20\">",
"      George MS, Rush AJ, Sackeim HA, Marangell LB. Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. Int J Neuropsychopharmacol 2003; 6:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/21\">",
"      Chae JH, Nahas Z, Lomarev M, et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003; 37:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/22\">",
"      Conway CR, Sheline YI, Chibnall JT, et al. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res 2006; 146:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/23\">",
"      Kosel M, Brockmann H, Frick C, et al. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res 2011; 191:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/24\">",
"      Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci 2011; 34:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/25\">",
"      Holtzheimer PE 3rd, Mayberg HS. Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 2010; 167:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/26\">",
"      Blomstedt P, Sj&ouml;berg RL, Hansson M, et al. Deep brain stimulation in the treatment of depression. Acta Psychiatr Scand 2011; 123:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/27\">",
"      Hauptman JS, DeSalles AA, Espinoza R, et al. Potential surgical targets for deep brain stimulation in treatment-resistant depression. Neurosurg Focus 2008; 25:E3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/28\">",
"      Rosa MA, Lisanby SH. Somatic treatments for mood disorders. Neuropsychopharmacology 2012; 37:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/29\">",
"      Lozano AM, Mayberg HS, Giacobbe P, et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008; 64:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/30\">",
"      Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011; 168:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/31\">",
"      Lozano AM, Giacobbe P, Hamani C, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 2012; 116:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/32\">",
"      Malone DA Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009; 65:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/33\">",
"      Bewernick BH, Hurlemann R, Matusch A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010; 67:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/34\">",
"      Jim&eacute;nez F, Velasco F, Salin-Pascual R, et al. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005; 57:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/35\">",
"      Sartorius A, Kiening KL, Kirsch P, et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol Psychiatry 2010; 67:e9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/36\">",
"      Neimat JS, Hamani C, Giacobbe P, et al. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry 2008; 165:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/37\">",
"      Schatzberg AF, Kraemer HC. Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression. Biol Psychiatry 2000; 47:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/38\">",
"      Goetz CG, Wuu J, McDermott MP, et al. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 2008; 23:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/39\">",
"      Blomstedt P, Bjartmarz H. Intracerebral infections as a complication of deep brain stimulation. Stereotact Funct Neurosurg 2012; 90:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/40\">",
"      Hirschfeld RM. Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 2011; 168:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/41\">",
"      McNeely HE, Mayberg HS, Lozano AM, Kennedy SH. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis 2008; 196:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/42\">",
"      Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/43\">",
"      Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 2009; 119:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/44\">",
"      Nahas Z, Anderson BS, Borckardt J, et al. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry 2010; 67:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/45\">",
"      Kopell BH, Halverson J, Butson CR, et al. Epidural cortical stimulation of the left dorsolateral prefrontal cortex for refractory major depressive disorder. Neurosurgery 2011; 69:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/46\">",
"      Abosch A, Cosgrove GR. Biological basis for the surgical treatment of depression. Neurosurg Focus 2008; 25:E2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/47\">",
"      Jasper HH. A historical perspective. The rise and fall of prefrontal lobotomy. Adv Neurol 1995; 66:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/48\">",
"      KUHN R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry 1958; 115:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/49\">",
"      BAILEY SD, BUCCI L, GOSLINE E, et al. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700. Ann N Y Acad Sci 1959; 80:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/50\">",
"      KILOH LG, CHILD JP, LATNER G. A controlled trial of iproniazid in the treatment of endogenous depression. J Ment Sci 1960; 106:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/51\">",
"      Sachdev P, Sachdev J. Sixty years of psychosurgery: its present status and its future. Aust N Z J Psychiatry 1997; 31:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/52\">",
"      Marino J&uacute;nior R, Cosgrove GR. Neurosurgical treatment of neuropsychiatric illness. Psychiatr Clin North Am 1997; 20:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/53\">",
"      Shah DB, Pesiridou A, Baltuch GH, et al. Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont) 2008; 5:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/54\">",
"      Hariz MI, Blomstedt P, Zrinzo L. Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus 2010; 29:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/55\">",
"      Dougherty DD, Rauch SL. Somatic therapies for treatment-resistant depression: new neurotherapeutic interventions. Psychiatr Clin North Am 2007; 30:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/56\">",
"      Sachdev PS, Sachdev J. Long-term outcome of neurosurgery for the treatment of resistant depression. J Neuropsychiatry Clin Neurosci 2005; 17:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/57\">",
"      Steele JD, Christmas D, Eljamel MS, Matthews K. Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biol Psychiatry 2008; 63:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5097/abstract/58\">",
"      Malhi GS, Bartlett JR. Depression: a role for neurosurgery? Br J Neurosurg 2000; 14:415.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16518 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-194.187.108.93-69C8FD1B77-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5097=[""].join("\n");
var outline_f4_62_5097=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H86073853\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9580630\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1161777\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86962738\">",
"      Assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9580637\">",
"      VAGUS NERVE STIMULATION (VNS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580644\">",
"      Outcome studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580651\">",
"      Safety and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580665\">",
"      Mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H671842\">",
"      Outside sources of patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9580672\">",
"      DEEP BRAIN STIMULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580679\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580686\">",
"      Safety and adverse side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580700\">",
"      Therapeutic mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H172385327\">",
"      Outside sources of patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9580707\">",
"      DIRECT CORTICAL STIMULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580714\">",
"      Effectiveness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580721\">",
"      Safety and adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580735\">",
"      Mechanism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9580742\">",
"      ABLATIVE NEUROSURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H322069\">",
"      Indication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580749\">",
"      Response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580756\">",
"      Risks and side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9580770\">",
"      Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86073853\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/16518\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/16518|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30678?source=related_link\">",
"      Deep brain stimulation for treatment of obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41305?source=related_link\">",
"      Overview of electroconvulsive therapy (ECT) for adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32105?source=related_link\">",
"      Surgical treatment of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/4/28741?source=related_link\">",
"      Surgical treatment of essential tremor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=related_link\">",
"      Treatment of dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=related_link\">",
"      Treatment of resistant depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/30/6633?source=related_link\">",
"      Unipolar depression in adults: Overview of neuromodulation procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/19/38201?source=related_link\">",
"      Unipolar depression in adults: Prognosis and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16682?source=related_link\">",
"      Unipolar depression in adults: Treatment with transcranial magnetic stimulation (TMS)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19578?source=related_link\">",
"      Vagus nerve stimulation therapy for the treatment of epilepsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5098="Overview of expressive language delay (late talking) in young children";
var content_f4_62_5098=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of expressive language delay (&ldquo;late talking&rdquo;) in young children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Laura Sices, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Marilyn Augustyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/62/5098/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/62/5098/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H19048021\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An overview of expressive language delay (\"late talking\") in young children is presented below. The etiology, evaluation, and treatment of speech and language disorders in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=see_link\">",
"     \"Etiology of speech and language disorders in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26343?source=see_link\">",
"     \"Evaluation and treatment of speech and language disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048028\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of communication and language skills is one of the most important tasks of early childhood. It is the key to early learning and social skills.",
"   </p>",
"   <p>",
"    Primary care providers will see many infants and preschool-age children whose early expressive language development and communication skills do not appear to be progressing as expected (\"late talkers\"). Receptive language delays often coexist with expressive delays but may not be suspected by the clinician or parents until the child is older. (See",
"    <a class=\"local\" href=\"#H19048052\">",
"     'Prevalence'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19048129\">",
"     'Cautions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some children with expressive language delay \"catch up\" during the preschool years (\"late bloomers\"), whereas others have persistent delay.",
"    <strong>",
"    </strong>",
"    (See",
"    <a class=\"local\" href=\"#H19048122\">",
"     'Natural history'",
"    </a>",
"    below.)",
"    <strong>",
"    </strong>",
"    Early evaluation can help to correctly identify late-talking children who will benefit from intervention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    additional evaluation. The developmental, psychosocial, and family histories are particularly important. Most children with language delays have no associated medical or physical findings, but the absence of such findings should not delay referral for functional evaluation of suspected delay. (See",
"    <a class=\"local\" href=\"#H19048136\">",
"     'Primary care evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There is no universally accepted definition of \"delay\" in developmental conditions, and different definitions may be used for research and treatment purposes. (See",
"    <a class=\"local\" href=\"#H19048035\">",
"     'Definitions'",
"    </a>",
"    below.) Specific program eligibility requirements should not discourage clinicians from identifying children with delays, although they may affect how information about such conditions is communicated to families. Even if the child does not qualify for services, awareness of a delay can lead to closer monitoring and provision of information to parents about ways to promote early language skills. (See",
"    <a class=\"local\" href=\"#H19048291\">",
"     'Prevention'",
"    </a>",
"    below.) All families of late-talking children benefit from guidance and close monitoring of their child's early communication development. The provision of appropriate supportive services and accommodations can help children with language delay achieve their full developmental and academic potential. (See",
"    <a class=\"local\" href=\"#H19048221\">",
"     'Management'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19048284\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048035\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Speech",
"      </strong>",
"      &ndash; The ability to produce vocal sounds.",
"     </li>",
"     <li>",
"      <strong>",
"       Expressive language",
"      </strong>",
"      &ndash; The ability to produce or use language.",
"     </li>",
"     <li>",
"      <strong>",
"       Receptive language",
"      </strong>",
"      &ndash; The ability to understand language.",
"     </li>",
"     <li>",
"      <strong>",
"       Gestural communication",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The ability to communicate nonverbally (eg, by pointing; nodding or shaking the head; using and interpreting facial expressions; using and coordinating eye contact). Gestural communication is necessary for successful interpersonal interactions.",
"      <br/>",
"      <br/>",
"      There is growing awareness of the importance of the development of nonverbal communication in the language and social development of young children. Absence of or delay in the development of nonverbal communication skills impacts the quality of overall communication development and can be a marker for more global delays and or atypical development, such as autism spectrum conditions [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features of autism spectrum disorders\", section on 'Communication'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Language delay &ndash;",
"      </strong>",
"      There is no universally accepted definition of \"delay\" in developmental conditions. For research purposes, children often are considered delayed if their performance on a standardized assessment of language is at least one standard deviation (SD) below the mean for age.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical threshold for concern (ie, \"red flag\") generally is the age at which 90 percent of typically developing children have attained a clinically predictive skill (eg, 12 months for the use of \"mama\" or \"dada\" to call a parent). Red flags for language delay are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef60203 \" href=\"UTD.htm?26/39/27260\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Treatment programs, such as early intervention (EI) (for children birth to 36 months), and special education provided through the public school system (for children &ge;3 years), may have more stringent eligibility criteria for children to qualify for services. The absence of a universal standard means that children may have a developmental condition without qualifying for services in some or even many communities or settings.",
"   </p>",
"   <p>",
"    Examples of criteria that may be used in different states, communities, or treatment programs include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scores of 1, 1.5, or even 2 SD below the mean for age.",
"     </li>",
"     <li>",
"      A certain percentage (eg, 25 percent, 40 percent) of delay compared with chronologic age. The percentage delay = [1 -",
"      <span class=\"nowrap\">",
"       (DA/CA)]",
"      </span>",
"      x 100 percent, where DA is the developmental age equivalent and CA is the chronologic age. As an example, an 18-month-old child who has language skills at a 12-month level is 33 percent delayed: [1 -",
"      <span class=\"nowrap\">",
"       (12/18)]",
"      </span>",
"      x 100 percent.",
"     </li>",
"     <li>",
"      A specific amount of delay (eg, skills that are &ge;1 year behind those expected for age).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048044\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048052\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 to 15 percent of two-year-old children have language delay, but only 4 to 5 percent remain delayed after three years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"     4",
"    </a>",
"    ]. Approximately 6 to 8 percent of school-age children have specific language impairments [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These statistics indicate that a certain proportion of young children with language delay catch up during the preschool years, but also that a certain proportion of school-age children with specific language impairment were not identified before school entry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048059\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knowledge of risk factors for expressive language delay may improve surveillance and screening.",
"   </p>",
"   <p>",
"    Risk factors for expressive language delay include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/7-12\">",
"     7-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Poverty",
"     </li>",
"     <li>",
"      Low parental educational attainment (ie, parent did not graduate from high school)",
"     </li>",
"     <li>",
"      Prematurity or low birth weight",
"     </li>",
"     <li>",
"      Family history of language delays, language disorders, or language-based learning disabilities (eg, dyslexia)",
"     </li>",
"     <li>",
"      Maternal depression &nbsp;",
"     </li>",
"     <li>",
"      Male sex",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Boys are somewhat more likely than girls to have specific language impairment (SLI) at kindergarten entry (8 versus 6 percent of children, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, conditions that are associated with language delay (eg, autism spectrum disorder, global developmental",
"    <span class=\"nowrap\">",
"     delay/intellectual",
"    </span>",
"    disability) are more common in boys than girls [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4698?source=see_link&amp;anchor=H8#H8\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=see_link&amp;anchor=H6#H6\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The identification of risk factors such as poverty, low parental educational attainment,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maternal depression may be helpful in addressing the global needs of the child and family, as well as the need for enrichment of the early learning environment (eg, through early intervention services). (See",
"    <a class=\"local\" href=\"#H19048228\">",
"     'Referral options'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048066\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two core aspects of diagnosis for children with expressive language delay: the functional level and the",
"    <span class=\"nowrap\">",
"     cause/etiology.",
"    </span>",
"    It is important to consider both aspects because they may have implications for treatment and eligibility for services. Community and educational programs, such as early intervention or special education, provide services based upon a child's developmental level or degree of delay. (See",
"    <a class=\"local\" href=\"#H19048035\">",
"     'Definitions'",
"    </a>",
"    above.) They also provide services to children who have certain diagnoses (eg, Down syndrome, autism, etc).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048073\">",
"    <span class=\"h2\">",
"     Developmental and behavioral conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental and behavioral conditions that involve expressive language delay are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef71932 \" href=\"UTD.htm?35/8/35980\">",
"     table 2",
"    </a>",
"    ). These diagnoses are made on the basis of patterns of delay or behavior.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048080\">",
"    <span class=\"h2\">",
"     Other diagnoses and contributing factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large number of medical, neurologic, metabolic, genetic, and environmental conditions can cause or contribute to early language delays, particularly in the context of a more global developmental condition. Selected conditions that may cause or contribute to early expressive language delay are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef50911 \" href=\"UTD.htm?9/19/9532\">",
"     table 3",
"    </a>",
"    ). For most children with isolated expressive language delays, a specific etiology beyond socioeconomic risk factors, maturational issues, or family history may not be found.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048087\">",
"    <span class=\"h2\">",
"     Invalid explanations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should be wary of the rationalizations listed below as explanations for language delay in a young child [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,16,17\">",
"     4,16,17",
"    </a>",
"    ]. Further evaluation or referral should not be delayed on the basis of these rationalizations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       \"He's a boy, and boys talk later than girls.\"",
"      </strong>",
"      A variant of this rationalization is:",
"      <strong>",
"       \"His father and uncle didn't talk until they turned three, and they turned out fine.\"",
"      </strong>",
"      <br/>",
"      <br/>",
"      This rationalization is invalid because speech and language milestones develop at a similar rate in boys and girls before three years of age.",
"      <strong>",
"      </strong>",
"      Boys actually are at increased risk for developmental conditions associated with language delays compared with girls, given the higher prevalence of autism spectrum disorders and global",
"      <span class=\"nowrap\">",
"       delays/cognitive",
"      </span>",
"      impairments in males. Male family members with early language delays might have benefited from evaluation and intervention if they had been available at the time.",
"     </li>",
"     <li>",
"      <strong>",
"       \"She's growing up in a bilingual home.\"",
"      </strong>",
"      <br/>",
"      <br/>",
"      Bilingual exposure and confusion about language generally does not explain a frank delay in language development in early childhood. When assessing the language skills of children who are exposed to two languages, clinicians should ask about the child's most complex skills in both languages. The amount and quality of exposure to each language may affect the rate of skill acquisition [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/16\">",
"       16",
"      </a>",
"      ]. Additional information about language development in bilingual children is available through the",
"      <a class=\"external\" href=\"file://www.asha.org/public/speech/development/learn.htm\">",
"       American Speech-Language-Hearing Association",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      <strong>",
"       \"His older brother talks for him.\"",
"      </strong>",
"      A variant of this rationalization is",
"      <strong>",
"       : \"I meet all of his needs as his parent; he doesn't need to talk to get what he wants.\"",
"      </strong>",
"      <br/>",
"      <br/>",
"      This rationalization is invalid because young children are naturally driven to communicate, not merely to get their needs met, but for social interaction, which typically developing children seek from the time they are infants. The absence of a drive to communicate and engage others is a red flag for developmental delays",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      conditions involving impairment in reciprocal social interaction (eg, autism spectrum disorders). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical features of autism spectrum disorders\", section on 'Social interaction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       \"He's not saying much, but he understands everything.\"",
"      </strong>",
"      <br/>",
"      <br/>",
"      While this may indeed be the case, clinicians should have a high index of suspicion for a receptive language delay in young children with expressive language delays. (See",
"      <a class=\"local\" href=\"#H19048129\">",
"       'Cautions'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       \"He talks fine at home, but his teacher at child care says he doesn't talk at all there, even though he doesn't mind going and has been going there for six months.\"",
"      </strong>",
"      <br/>",
"      <br/>",
"      Before this explanation is accepted, selective mutism, an anxiety disorder, must be considered. Children with selective mutism speak only in familiar settings, often only with a few close family members. Although overall language development may be normal, children with selective mutism are difficult to assess. They require",
"      <span class=\"nowrap\">",
"       intervention/therapy",
"      </span>",
"      to address anxiety, which impacts their social-emotional and overall development.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048094\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with expressive language delay may present with delayed language milestones, drooling, or behavioral problems.",
"   </p>",
"   <p>",
"    Normal language milestones are provided in the table (",
"    <a class=\"graphic graphic_table graphicRef58598 \" href=\"UTD.htm?16/20/16717\">",
"     table 4",
"    </a>",
"    ). Although there is no universally accepted definition for language delay, the clinical threshold for concern (ie, \"red flag\") generally is the age at which 90 percent of typically developing children have attained a clinically predictive skill (eg, 12 months for the use of \"mama\" or \"dada\" to call a parent). Red flags for language delay are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef60203 \" href=\"UTD.htm?26/39/27260\">",
"     table 1",
"    </a>",
"    ). Additional evaluation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    referral may be warranted for children with red flags for language delay. (See",
"    <a class=\"local\" href=\"#H19048136\">",
"     'Primary care evaluation'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19048270\">",
"     'Approach to referral'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children with apraxia of speech or cerebral palsy involving the oral musculature are likely to continue drooling beyond infancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=see_link&amp;anchor=H7#H7\">",
"     \"Etiology of speech and language disorders in children\", section on 'Apraxia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29209?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical features of cerebral palsy\", section on 'Speech impairment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with language delays may present with behavioral issues [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/18\">",
"     18",
"    </a>",
"    ]. Parents may not recognize their child's language delay, but generally are keenly aware of temper tantrums and other behavioral self-regulation difficulties. For this reason, the language development of toddlers and preschool children whose parents raise behavioral concerns should be monitored closely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048122\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant percentage (as many as 60 percent) of children with isolated early expressive language delays appear to spontaneously \"catch up\" in their language milestones between age two and three years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/19\">",
"     19",
"    </a>",
"    ]. However, early language delays may be an important marker for future language-based learning differences and difficulties [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/20-26\">",
"     20-26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6409?source=see_link&amp;anchor=H12#H12\">",
"     \"Normal reading development and etiology of reading difficulty in children\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048129\">",
"    <span class=\"h2\">",
"     Cautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not possible to accurately predict, at the time of identification, which children with isolated expressive language delays will catch up without special services and which will have persistent language problems [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,16,19\">",
"     4,16,19",
"    </a>",
"    ]. Historically, the majority of children with language delays and disorders have not been identified before school entry [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Accurate prediction of persistent language difficulties is hampered by the difficulty in identifying coexistent receptive language delay, which is associated with increased risk of persistent language problems. (See",
"    <a class=\"local\" href=\"#H19048284\">",
"     'Prognosis'",
"    </a>",
"    below.) Receptive language delay may not be suspected by the clinician (or parent). Primary care clinicians may not objectively screen for receptive language skills, which are difficult to assess subjectively. Parents may report that the child responds to directions in the context of daily routines, but the child actually may be responding to the routine or parental gestures or eye gaze.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048136\">",
"    <span class=\"h1\">",
"     PRIMARY CARE EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048144\">",
"    <span class=\"h2\">",
"     Surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental surveillance consists of ongoing, longitudinal attention to young children's development, including the eliciting of parental concerns,",
"    <span class=\"nowrap\">",
"     history/milestone",
"    </span>",
"    information, knowledge of the family and caregiving environment, observations of the child, and information from the physical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/49/26394?source=see_link&amp;anchor=H2#H2\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Routine developmental surveillance may identify risk factors for or parental concerns about language delay. Concerns raised during routine surveillance should prompt further action, which might include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Developmental screening within the primary care practice using a validated screening tool, or",
"     </li>",
"     <li>",
"      Referral for further evaluation through community-based organizations (eg, early intervention if the child is &lt;3 years of age [in the United States]), evaluation within the medical system (eg, neurology), or evaluation by a specific therapist (eg, speech and language pathologist). (See",
"      <a class=\"local\" href=\"#H19048228\">",
"       'Referral options'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The specific action that is taken may depend on the availability of resources in the clinician's community.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048151\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Pediatrics (AAP) recommends formal developmental screening using a validated screening tool at 9, 18, and 24 or 30 months and autism-specific screening at the 18- and 24-month visits as part of routine well-child care [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Formal screening is also recommended whenever the parent or clinician has a developmental concern about the child [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35097?source=see_link&amp;anchor=H13#H13\">",
"     \"Surveillance and screening for autism spectrum disorders in primary care\", section on 'Guidelines for surveillance and screening'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/49/26394?source=see_link&amp;anchor=H9015915#H9015915\">",
"     \"Developmental-behavioral surveillance and screening in primary care\", section on 'Milestones-focused developmental-behavioral screening tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The United States Preventive Services Task Force determined that there is insufficient evidence to recommend for or against the routine use of brief, formal screening tools to detect speech and language delays in children up to five years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/33\">",
"     33",
"    </a>",
"    ]. However, a language-specific screen may be useful for secondary screening (ie, screening of a child who appears to be at increased risk, whether because of family history, child risk factors, or presenting history in the office). (See",
"    <a class=\"local\" href=\"#H19048059\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Language-specific screens that can be used in the primary care setting include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/16,31\">",
"     16,31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Early Language Milestone (ELM), second edition (for children from birth to three years) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The Clinical Adaptive",
"      <span class=\"nowrap\">",
"       Test/Clinical",
"      </span>",
"      Linguistic and Auditory Milestone Scale",
"      <span class=\"nowrap\">",
"       (CAT/CLAMS),",
"      </span>",
"      for children 3 to 36 months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, parent-report inventories, such as the Language Development Survey [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/37,38\">",
"     37,38",
"    </a>",
"    ] or the MacArthur Communicative Development Inventories-Short Form [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/39\">",
"     39",
"    </a>",
"    ], have been validated for use in children 18 to 24 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,16,39\">",
"     4,16,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048158\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the history in the child with an expressive language delay include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,17\">",
"     4,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parental concerns about hearing, language development, or social development",
"     </li>",
"     <li>",
"      Risk factors for hearing loss",
"     </li>",
"     <li>",
"      Prenatal exposures and prenatal or perinatal complications",
"     </li>",
"     <li>",
"      Developmental and adaptive skills, including loss of developmental skills",
"     </li>",
"     <li>",
"      Parents' and siblings' level of educational attainment",
"     </li>",
"     <li>",
"      Play and social interaction skills",
"     </li>",
"     <li>",
"      Family history of language delays, learning issues, childhood hearing loss, school failure",
"     </li>",
"     <li>",
"      The linguistic environment (ie, the quantity and quality of exposure to language and the ways in which language is used: to communicate, express ideas, label everyday events, etc)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048165\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination may disclose clues to the underlying etiology of expressive language delay. Particular attention should be paid to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight, length, and head circumference (and growth trajectories). Abnormal growth parameters may be clues to a genetic or global condition (eg, Klinefelter syndrome) or socioeconomic concerns (eg, poverty). (See appropriate topic reviews).",
"     </li>",
"     <li>",
"      General appearance, looking for dysmorphic features and minor malformations (eg, transverse palmar crease, clinodactyly)",
"      <strong>",
"      </strong>",
"      that may suggest a genetic syndrome or intrauterine infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=see_link&amp;anchor=H11#H11\">",
"       \"Approach to congenital malformations\", section on 'Patterns of defects'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Social interaction (eg, eye contact, pointing to objects).",
"     </li>",
"     <li>",
"      The ear. Abnormalities of the external ear may be a clue to hearing loss; tympanic membrane scarring (",
"      <a class=\"graphic graphic_picture graphicRef78073 \" href=\"UTD.htm?16/62/17379\">",
"       picture 1",
"      </a>",
"      ) may indicate chronic or persistent otitis media (with associated conductive hearing loss). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=see_link&amp;anchor=H6#H6\">",
"       \"Congenital anomalies of the ear\", section on 'Outer ear malformations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=see_link\">",
"       \"Etiology of hearing impairment in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link&amp;anchor=H6#H6\">",
"       \"Otitis media with effusion (serous otitis media) in children\", section on 'Hearing loss'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The mouth and oral motor examination. Is the palate intact? Is the uvula bifid? Does the tongue have normal mobility? What is the condition of the teeth? Is there drooling? Can the child purse and smack the lips? Thrust, click, extend, and wiggle the tongue? Puff the cheeks? Shout and whisper [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/40\">",
"       40",
"      </a>",
"      ]? Asking the child to repeat sounds like \"pa, ta, ka\" will help to identify children with abnormal speech and dyspraxic oral motor function.",
"     </li>",
"     <li>",
"      The neurologic examination. Abnormal muscle tone, strength, or reflexes may be a clue to a neurologic condition.",
"     </li>",
"     <li>",
"      The skin examination. Abnormal pigmentation may indicate a neurocutaneous disorder (eg, neurofibromatosis, tuberous sclerosis complex). Specific patterns or locations of bruising or scars may suggest physical abuse. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link&amp;anchor=H10#H10\">",
"       \"Physical abuse in children: Epidemiology and clinical manifestations\", section on 'Bruising patterns'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048172\">",
"    <span class=\"h2\">",
"     Hearing test",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children with suspected language delay should be referred for a hearing test by an audiologist. Children younger than three or four years typically cannot be adequately screened for hearing impairment in the primary care office in cases where a language delay is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of hearing impairment in children\", section on 'Formal audiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048179\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the findings from the history and examination, laboratory tests that may be warranted in a child with expressive language delay include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete blood count to exclude anemia (this may already have been performed as part of routine care). Iron deficiency is associated with impaired development in young children. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link&amp;anchor=H20317270#H20317270\">",
"       \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\", section on 'Neurodevelopmental'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Venous blood lead level, particularly if child mouths objects or lives in older housing (this may already have been performed as part of routine care). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=see_link&amp;anchor=H7#H7\">",
"       \"Childhood lead poisoning: Clinical manifestations and diagnosis\", section on 'Neurologic'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Genetic tests (eg, high-resolution chromosomes, DNA test for fragile X syndrome, and others) generally are not ordered by primary care clinicians without guidance from a specialist. However, they often are recommended for children with language delays that are part of a more generalized condition, such as a global developmental delay or autism spectrum disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=see_link&amp;anchor=H6#H6\">",
"       \"Intellectual disability (mental retardation) in children: Evaluation\", section on 'Diagnostic approach'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link&amp;anchor=H27#H27\">",
"       \"Diagnosis of autism spectrum disorders\", section on 'Genetic testing'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048186\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending on the child's presentation and other areas of delay or concern (eg, social interaction, fine motor), the major considerations in the differential diagnosis of expressive language delay are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated language delay",
"     </li>",
"     <li>",
"      Language delay as part of a more general developmental condition",
"     </li>",
"     <li>",
"      Hearing impairment",
"     </li>",
"     <li>",
"      Poor linguistic environment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These disorders usually can be distinguished through developmental and behavioral history and physical examination, as described below [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,16\">",
"     4,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolated language delay encompasses expressive language delay with or without receptive language delay. There are two main categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Developmental language delay (expressive, receptive, or mixed). Developmental language delay (also called maturational delay) is a diagnosis made in younger children who are in the early developmental period. These delays may resolve in some children, or progress to a more specific diagnosis at the age of school entry. Some see this as a diagnosis of exclusion that can only be made definitively in retrospect [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,17\">",
"       4,17",
"      </a>",
"      ]. However, making the functional diagnosis allows children to receive treatment services while other causes of language delay are being evaluated.",
"     </li>",
"     <li>",
"      Specific language impairment (expressive, receptive, or mixed) (also called developmental language disorder). Characteristics of specific language impairment include a limited understanding or production of vocabulary, misuse of words and their meanings, difficulty expressing or following ideas, immature grammatical patterns (eg, poor understanding or use of the plural (-s) or past tense (-ed), difficulty following directions, and altered patterns of conversation) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/17\">",
"       17",
"      </a>",
"      ]. Specific language impairment should be considered when language skills are delayed more than other abilities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Expressive language delay may occur as part of more general developmental condition, such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Global developmental",
"      <span class=\"nowrap\">",
"       delay/intellectual",
"      </span>",
"      disability; in addition to language delay, children with global developmental",
"      <span class=\"nowrap\">",
"       delay/intellectual",
"      </span>",
"      disability have abnormalities in other streams of development (eg, adaptive skills) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=see_link&amp;anchor=H12#H12\">",
"       \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\", section on 'Clinical presentation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Autism spectrum conditions; in addition to language delay, children with autism spectrum conditions have abnormalities in social interaction and behavior (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features of autism spectrum disorders\", section on 'Overview'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Selective",
"      <span class=\"nowrap\">",
"       mutism/anxiety;",
"      </span>",
"      children with selective mutism speak normally in familiar settings with close individuals",
"     </li>",
"     <li>",
"      Apraxia of speech (impairment in the ability to program the speech musculature to select, plan, organize, and initiate a motor pattern) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=see_link&amp;anchor=H7#H7\">",
"       \"Etiology of speech and language disorders in children\", section on 'Apraxia'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cerebral palsy; abnormal function of oropharyngeal muscles may contribute to language problems in children with cerebral palsy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29209?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical features of cerebral palsy\", section on 'Speech impairment'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Normal receptive language skills help to exclude global developmental",
"    <span class=\"nowrap\">",
"     delay/intellectual",
"    </span>",
"    disability and autism spectrum disorders. Normal gross and fine motor skills are helpful in excluding more general neurodevelopmental disorders (eg, cerebral palsy) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"     4",
"    </a>",
"    ]. Abnormalities in nonverbal communication (eg, lack of eye contact, pointing) may suggest intellectual disability or autism spectrum disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hearing impairment may be suspected based upon the pattern of the child's understanding and production of speech. Children with moderate or severe hearing loss typically have difficulty hearing and producing sounds with high frequency and low energy (eg, \"f\", \"s\", \"th\") [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/16\">",
"     16",
"    </a>",
"    ]. Children with hearing impairment usually have normal visual language development (eg, eye contact) and social interaction skills [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/17\">",
"     17",
"    </a>",
"    ]. Normal receptive language skills generally exclude significant hearing loss but cannot exclude subtle hearing impairment. Children with language delay should undergo objective hearing evaluation by an audiologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of hearing impairment in children\", section on 'Formal audiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The size of a child's vocabulary and the maturity of his or her grammar are associated with the quality and quantity of parental input [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/16\">",
"     16",
"    </a>",
"    ]. A number of factors may contribute to a poor linguistic environment (eg, low parental educational attainment, child neglect or abuse, maternal depression, etc). A thorough social history generally identifies factors that may contribute to a poor linguistic environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048221\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management for language delays is multimodal and depends upon:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The child's age",
"     </li>",
"     <li>",
"      Child and family risk factors",
"     </li>",
"     <li>",
"      Findings from the physical examination and hearing test",
"     </li>",
"     <li>",
"      The availability of treatment resources in a given community",
"     </li>",
"     <li>",
"      The eligibility criteria of different services and agencies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048228\">",
"    <span class=\"h2\">",
"     Referral options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral options for young children with expressive language delay may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Early intervention services",
"     </li>",
"     <li>",
"      Special education services",
"     </li>",
"     <li>",
"      Speech and language therapy",
"     </li>",
"     <li>",
"      Medical specialist",
"     </li>",
"     <li>",
"      General support services",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the United States, the early intervention program (EI) is mandated to provide an initial evaluation for children younger than three years who are referred for developmental concerns. Ongoing services are provided for children who meet eligibility criteria (through Part C of the Individuals with Disabilities Education Act). The percentage of children who are served by EI varies widely by state (range 1.3 to 7.5; mean 2.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/2,41\">",
"     2,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=see_link&amp;anchor=H13#H13\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Individuals with Disabilities Education Act'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children three years of age or older who require evaluation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    who have a diagnosed language delay or language disorder may be referred for special education evaluation and services through the local public school district. These services are provided",
"    <strong>",
"    </strong>",
"    through Part B of the Individuals with Disabilities Education Act [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=see_link&amp;anchor=H13#H13\">",
"     \"Definitions of specific learning disability and laws pertaining to learning disabilities\", section on 'Individuals with Disabilities Education Act'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children of any age who are suspected of having a significant language delay or who have been diagnosed with language delay or disorder may be referred for speech and language therapy. Speech and language therapy services may be provided independently",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    within the context of an early intervention or special education program. Speech and language therapy services may be covered by the child's medical insurance. Meta-analyses of randomized controlled trials indicate that compared with no therapy, speech therapy is effective for children with phonological difficulties (standardized mean difference [SMD] 0.44, 95% CI 0.01-0.86) or expressive vocabulary difficulties (SMD 0.89, 95% CI 0.21-1.56) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Longer duration of therapy (&gt;8 weeks) was associated with greater improvement.",
"   </p>",
"   <p>",
"    Referral to a medical specialist (eg, developmental behavioral pediatrician, child neurologist, geneticist) may be warranted if the child has clinical findings compatible with a specific disorder (eg, specific language impairment, autism spectrum disorder, verbal apraxia, etc.) (",
"    <a class=\"graphic graphic_table graphicRef71932 \" href=\"UTD.htm?35/8/35980\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50911 \" href=\"UTD.htm?9/19/9532\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    General types of services for low-income families",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    families that would benefit from parenting support include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parent training activities through community-based parenting centers.",
"     </li>",
"     <li>",
"      High-quality child care (eg, licensed child care or preschool program, rather than home child care or kinship care).",
"     </li>",
"     <li>",
"      Head Start and Early Head Start. Head Start programs serve families based on low family income. However, Head Start programs also are mandated to serve children with developmental delays, who must comprise 10 percent of the children served.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048270\">",
"    <span class=\"h2\">",
"     Approach to referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for referral to an early intervention program, speech and language therapist, or medical specialist (eg, developmental behavioral pediatrician, child neurologist, geneticist) depend to some extent upon the mode of identification and the level of concern of the clinician",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parents.",
"   </p>",
"   <p>",
"    It is not possible to distinguish, at the time of identification, the child who will continue to have language difficulties and for whom intervention would be beneficial from the child with a maturational delay for whom treatment might be unnecessary [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, the clinician must balance the provision of reassurance with the provision of information about expected language milestones and the availability of evaluation and treatment services, if needed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that children with hearing delay or expressive language delay that is part of a more general developmental condition (eg, autism, Down syndrome) be referred to the appropriate medical specialist for additional evaluation and management.",
"     </li>",
"     <li>",
"      We recommend that children with suspected language delay who are identified through surveillance or screening (ie, children who have red flags for language delay (",
"      <a class=\"graphic graphic_table graphicRef60203 \" href=\"UTD.htm?26/39/27260\">",
"       table 1",
"      </a>",
"      )) be promptly referred for intervention. Referral options are discussed above. (See",
"      <a class=\"local\" href=\"#H19048228\">",
"       'Referral options'",
"      </a>",
"      above.) Such children also should be referred for additional evaluation as indicated by the initial evaluation (eg, neurologist, geneticist, etc.).",
"      <br/>",
"      <br/>",
"      The \"watch and wait\" approach, which has traditionally been adopted by some primary care providers for children with isolated early language delay, contributes to delayed identification and intervention for children with persistent language delays [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/44\">",
"       44",
"      </a>",
"      ]. Given the current knowledge about the critical importance of early brain development and benefits of early (as opposed to later) intervention in affecting neural pathways [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,45\">",
"       4,45",
"      </a>",
"      ], providing early referral to families of young children with suspected developmental delays is strongly recommended.",
"     </li>",
"     <li>",
"      When the parent is concerned about language delay, we suggest that the child be referred for further screening",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      evaluation of the child's language development, even if the clinician is not concerned. Parental concerns are a reliable source of information about the child's development, and reassurance should not be provided without additional screening or evaluation [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Referral options are discussed above. (See",
"      <a class=\"local\" href=\"#H19048228\">",
"       'Referral options'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When the clinician is concerned about language delay, but the parent is not, communication skills and general development should be closely monitored. The child should return for developmental screening sooner than the next scheduled routine well-child visit. This is particularly important for children who are older than two years; waiting until the three-year-old well-child visit may lead to missed opportunities for early intervention.",
"     </li>",
"     <li>",
"      Communication skills and general development also should be closely monitored when the clinician is uncertain of whether the child has a language delay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048277\">",
"    <span class=\"h2\">",
"     Role of primary care provider",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary care providers and the medical home play a critical role for families of children undergoing evaluation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment for expressive language delay.",
"   </p>",
"   <p>",
"    The primary care provider's review of reports of diagnostic assessments (from medical specialists, early intervention, speech-language pathologist, etc) can help to reinforce the family's understanding of the diagnosis or level of delays, and treatment options.",
"   </p>",
"   <p>",
"    The primary care provider also provides follow-up and care coordination, which are crucial to the success of treatment intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, the primary care provider can monitor for potential long-term sequelae of early language delay (eg, academic failure or underachievement, neuropsychiatric disorders). (See",
"    <a class=\"local\" href=\"#H19048122\">",
"     'Natural history'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048284\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for expressive language delay depends upon the underlying etiology. Children with speech and language problems that persist beyond five years of age may continue to have difficulty into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not possible to predict the course of early language delay at the time of identification in an individual child [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,16,19\">",
"     4,16,19",
"    </a>",
"    ]. However, in longitudinal studies, factors that have been associated with resolution during the preschool years include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/48-53\">",
"     48-53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated",
"      <span class=\"nowrap\">",
"       speech/language",
"      </span>",
"      problem (ie, normal developmental milestones in other domains)",
"     </li>",
"     <li>",
"      Average to above-average intelligence",
"     </li>",
"     <li>",
"      No receptive language difficulties",
"     </li>",
"     <li>",
"      Normal nonverbal skills and gestural communication",
"     </li>",
"     <li>",
"      Capacity for symbolic thinking (eg, playing with dolls)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Expressive language delay does not appear to be a risk for behavioral and emotional disturbances during school-age or adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048291\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of things parents can do to enhance or promote their child's language development. These include [",
"    <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reading aloud to the child (increases the amount and diversity of language) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/55-57\">",
"       55-57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Avoiding baby talk and providing exposure to advanced or unusual words; this is readily done by sharing books",
"     </li>",
"     <li>",
"      Engaging in dialogic reading, a style of book-sharing in which parents encourage toddlers and preschool-age children to comment on pictures and the story to engage the child and promote conversation [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/58\">",
"       58",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Narrating daily activities, in which the parent talks aloud to the child as they are going through the day, explaining what they are doing and commenting to the child (eg, \"Now I'm washing the dishes. I'll start with your bowl.\")",
"     </li>",
"     <li>",
"      Listening to the child and responding to the child's conversational lead, repeating and expanding on the child's conversational output [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/4,59\">",
"       4,59",
"      </a>",
"      ] &nbsp;",
"     </li>",
"     <li>",
"      Limiting or reducing media exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?4/62/5098/abstract/60-62\">",
"       60-62",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Asking questions and having the child indicate a choice in response",
"     </li>",
"     <li>",
"      Accompanying words with gestures to make them more understandable",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048298\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list of resources for parents and clinicians related to language delay or language disorders is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef74444 \" href=\"UTD.htm?24/14/24813\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19048305\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Language development is the key to early learning and social skills. Early and appropriate intervention for expressive language delay can help children achieve their full developmental and academic potential. (See",
"      <a class=\"local\" href=\"#H19048028\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no universally accepted definition of \"delay\" in developmental conditions. The clinical threshold for concern generally is the age at which 90 percent of typically developing children have attained a clinically predictive skill (",
"      <a class=\"graphic graphic_table graphicRef60203 \" href=\"UTD.htm?26/39/27260\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19048035\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for expressive language delay include poverty; parents who did not graduate from high school; prematurity or low birth weight; family history of language delays, language disorders, or language-based learning disabilities; maternal depression; and male sex. (See",
"      <a class=\"local\" href=\"#H19048059\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Expressive language delay has a wide range of causes and contributing factors (",
"      <a class=\"graphic graphic_table graphicRef71932 \" href=\"UTD.htm?35/8/35980\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50911 \" href=\"UTD.htm?9/19/9532\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19048073\">",
"       'Developmental and behavioral conditions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19048080\">",
"       'Other diagnoses and contributing factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Explanations for expressive language delay that should",
"      <strong>",
"       not",
"      </strong>",
"      allay concern or delay",
"      <span class=\"nowrap\">",
"       evaluation/intervention",
"      </span>",
"      include male sex; bilingual household; older siblings; apparent normal receptive language skills; or use of expressive language in the home, but not at child care. (See",
"      <a class=\"local\" href=\"#H19048087\">",
"       'Invalid explanations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As many as 60 percent",
"      <strong>",
"      </strong>",
"      of children with isolated early expressive language delays appear to spontaneously \"catch up\" in their language milestones between age two and three years. However, early language delays may be an important marker for future language-based learning differences and difficulties. (See",
"      <a class=\"local\" href=\"#H19048122\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is not possible to accurately predict, at the time of identification, which children will catch up without special services and which will have persistent language problems. (See",
"      <a class=\"local\" href=\"#H19048129\">",
"       'Cautions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surveillance and screening for language delay should occur as part of routine well-child care. (See",
"      <a class=\"local\" href=\"#H19048144\">",
"       'Surveillance'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19048151\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and physical examination of the child with suspected language delay should focus on identification of risk factors, contributing factors, and disorders that are associated with language delay (",
"      <a class=\"graphic graphic_table graphicRef71932 \" href=\"UTD.htm?35/8/35980\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef50911 \" href=\"UTD.htm?9/19/9532\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19048158\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19048165\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Young children with expressive language delay should be referred to an audiologist for a hearing test. The laboratory evaluation should include a complete blood count and blood lead level. Genetic testing may be warranted in children who have language delay as part of a more general neurodevelopmental condition. (See",
"      <a class=\"local\" href=\"#H19048172\">",
"       'Hearing test'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19048179\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of expressive language delay includes isolated language delay; language delay as part of a more general developmental condition; hearing impairment; and a poor linguistic environment. These disorders usually can be distinguished through developmental and behavioral history and physical examination. (See",
"      <a class=\"local\" href=\"#H19048186\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Referral options for young children with expressive language delay may include early intervention services, special education service, speech and language therapy, medical specialist, and general support services. (See",
"      <a class=\"local\" href=\"#H19048228\">",
"       'Referral options'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indications for referral to an early intervention program, speech and language therapist, medical specialist, or general support services depend upon the mode of identification and the level of concern of the clinician",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      parents (see",
"      <a class=\"local\" href=\"#H19048270\">",
"       'Approach to referral'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend that children with suspected language delay who are identified through surveillance or screening be promptly referred for evaluation and intervention.",
"     </li>",
"     <li>",
"      We suggest referral for further screening",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      evaluation of language development if the parent is concerned about language delay (even if the clinician is not concerned).",
"     </li>",
"     <li>",
"      Communication skills and general development should be closely monitored if the clinician is uncertain of whether the child has an expressive language delay or if the clinician is concerned about language delay but the parent is not.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are a number of things parents can do to enhance or promote their child's language development, including reading aloud to the child and encouraging the child to comment on pictures or the story; narrating daily activities; listening to the child and responding to his or her conversational lead; limiting television and media exposure; asking a lot of questions; and accompanying words with gestures to make them more understandable. (See",
"      <a class=\"local\" href=\"#H19048291\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/1\">",
"      Dawson G, Toth K, Abbott R, et al. Early social attention impairments in autism: social orienting, joint attention, and attention to distress. Dev Psychol 2004; 40:271.",
"     </a>",
"    </li>",
"    <li>",
"     Part C updates, 10th ed, Goode S, Lazara A, Danaher J, (Eds), Chapel Hill, NC, The University of North Carolina, FPG Child Development Institute, National Early Childhood Technical Assistance Center 2008.",
"    </li>",
"    <li>",
"     Danaher, J. Eligibility policies and practices for young children under Part B of IDEA, NECTAC Notes, 2007. p.24. file://www.nectac.org/~pdfs/pubs/nnotes24.pdf (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/4\">",
"      Stein MT, Parker S, Coplan J, Feldman H. Expressive language delay in a toddler. J Dev Behav Pediatr 2001; 22:S99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/5\">",
"      Tomblin JB, Records NL, Buckwalter P, et al. Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res 1997; 40:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/6\">",
"      Shriberg LD, Tomblin JB, McSweeny JL. Prevalence of speech delay in 6-year-old children and comorbidity with language impairment. J Speech Lang Hear Res 1999; 42:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/7\">",
"      Stevens GD. Gradients in the health status and developmental risks of young children: the combined influences of multiple social risk factors. Matern Child Health J 2006; 10:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/8\">",
"      Roth J, Figlio DN, Chen Y, et al. Maternal and infant factors associated with excess kindergarten costs. Pediatrics 2004; 114:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/9\">",
"      Horwitz SM, Irwin JR, Briggs-Gowan MJ, et al. Language delay in a community cohort of young children. J Am Acad Child Adolesc Psychiatry 2003; 42:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/10\">",
"      Dollaghan CA, Campbell TF, Paradise JL, et al. Maternal education and measures of early speech and language. J Speech Lang Hear Res 1999; 42:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/11\">",
"      Barre N, Morgan A, Doyle LW, Anderson PJ. Language abilities in children who were very preterm and/or very low birth weight: a meta-analysis. J Pediatr 2011; 158:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/12\">",
"      van Noort-van der Spek IL, Franken MC, Weisglas-Kuperus N. Language functions in preterm-born children: a systematic review and meta-analysis. Pediatrics 2012; 129:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/13\">",
"      Yeargin-Allsopp M, Rice C, Karapurkar T, et al. Prevalence of autism in a US metropolitan area. JAMA 2003; 289:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/14\">",
"      Yeargin-Allsopp M, Drews CD, Decoufl&eacute; P, Murphy CC. Mild mental retardation in black and white children in metropolitan Atlanta: a case-control study. Am J Public Health 1995; 85:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/15\">",
"      Bertrand J, Mars A, Boyle C, et al. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001; 108:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/16\">",
"      Feldman HM. Evaluation and management of language and speech disorders in preschool children. Pediatr Rev 2005; 26:131.",
"     </a>",
"    </li>",
"    <li>",
"     Coplan, J. Language delays. In: The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd ed, Augustyn, M, Zuckerman, B, Caronna, EB (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.258.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/18\">",
"      Caulfield MB, Fischel JE, DeBaryshe BD, Whitehurst GJ. Behavioral correlates of developmental expressive language disorder. J Abnorm Child Psychol 1989; 17:187.",
"     </a>",
"    </li>",
"    <li>",
"     Law, J, Boyle, J, Harris, F, et al. Screening for speech and language delay: A systematic review of the literature file://www.hta.ac.uk/fullmono/mon209.pdf (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/20\">",
"      Storch SA, Whitehurst GJ. Oral language and code-related precursors to reading: evidence from a longitudinal structural model. Dev Psychol 2002; 38:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/21\">",
"      Beitchman JH, Wilson B, Brownlie EB, et al. Long-term consistency in speech/language profiles: I. Developmental and academic outcomes. J Am Acad Child Adolesc Psychiatry 1996; 35:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/22\">",
"      Beitchman JH, Brownlie EB, Inglis A, et al. Seven-year follow-up of speech/language-impaired and control children: speech/language stability and outcome. J Am Acad Child Adolesc Psychiatry 1994; 33:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/23\">",
"      Rescorla L, Schwartz E. Outcome of toddlers with specific expressive language delay. Appl Psycholinguist 1990; 11:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/24\">",
"      Aram DM, Ekelman BL, Nation JE. Preschoolers with language disorders: 10 years later. J Speech Hear Res 1984; 27:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/25\">",
"      Glogowska M, Roulstone S, Peters TJ, Enderby P. Early speech- and language-impaired children: linguistic, literacy, and social outcomes. Dev Med Child Neurol 2006; 48:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/26\">",
"      Stothard SE, Snowling MJ, Bishop DV, et al. Language-impaired preschoolers: a follow-up into adolescence. J Speech Lang Hear Res 1998; 41:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/27\">",
"      Palfrey JS, Singer JD, Walker DK, Butler JA. Early identification of children's special needs: a study in five metropolitan communities. J Pediatr 1987; 111:651.",
"     </a>",
"    </li>",
"    <li>",
"     Hebbeler, K, Spiker, D, Bailey, D, et al. Early Intervention for Infants &amp; Toddlers with Disabilities and their Families: Participants, Services, and Outcomes. file://www.sri.com/neils/pdfs/NEILS_Report_02_07_Final2.pdf (Accessed on September 13, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/29\">",
"      Bailey DB Jr, Hebbeler K, Scarborough A, et al. First experiences with early intervention: a national perspective. Pediatrics 2004; 113:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/30\">",
"      Dworkin PH. British and American recommendations for developmental monitoring: the role of surveillance. Pediatrics 1989; 84:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/31\">",
"      Council on Children With Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006; 118:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/32\">",
"      Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007; 120:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/33\">",
"      US Preventive Services Task Force. Screening for speech and language delay in preschool children: recommendation statement. Pediatrics 2006; 117:497.",
"     </a>",
"    </li>",
"    <li>",
"     Coplan J. The Early Language Milestone Scale, 2nd ed. PRO-ED Austin TX 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/35\">",
"      Wachtel RC, Shapiro BK, Palmer FB, et al. CAT/CLAMS. A tool for the pediatric evaluation of infants and young children with developmental delay. Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale. Clin Pediatr (Phila) 1994; 33:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/36\">",
"      Voigt RG, Brown FR 3rd, Fraley JK, et al. Concurrent and predictive validity of the cognitive adaptive test/clinical linguistic and auditory milestone scale (CAT/CLAMS) and the Mental Developmental Index of the Bayley Scales of Infant Development. Clin Pediatr (Phila) 2003; 42:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/37\">",
"      Rescorla L. The Language Development Survey: a screening tool for delayed language in toddlers. J Speech Hear Disord 1989; 54:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/38\">",
"      Rescorla L, Alley A. Validation of the language development survey (LDS): a parent report tool for identifying language delay in toddlers. J Speech Lang Hear Res 2001; 44:434.",
"     </a>",
"    </li>",
"    <li>",
"     Fenson L, Dale PS, Reznick JS, et al. MacArthur Communcative Development INventories, User's Guide and Technical Manual. Singular Publishing Group, Inc., San Diego, CA 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/40\">",
"      Montgomery TR. When \"not talking\" is the chief complaint. Contemp Pediatr 1994; 11:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/41\">",
"      McManus B, McCormick MC, Acevedo-Garcia D, et al. The effect of state early intervention eligibility policy on participation among a cohort of young CSHCN. Pediatrics 2009; 124 Suppl 4:S368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/42\">",
"      Law J, Garrett Z, Nye C. The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis. J Speech Lang Hear Res 2004; 47:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/43\">",
"      Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder. Cochrane Database Syst Rev 2003; :CD004110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/44\">",
"      Buschmann A, Jooss B, Rupp A, et al. Children with developmental language delay at 24 months of age: results of a diagnostic work-up. Dev Med Child Neurol 2008; 50:223.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Integrating the Science of Early Childhood Development. From neurons to neighborhoods: the science of early childhood development, Shonkoff JP, Phillips DA (Eds), National Academy Press, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/46\">",
"      Sachse S, Von Suchodoletz W. Early identification of language delay by direct language assessment or parent report? J Dev Behav Pediatr 2008; 29:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/47\">",
"      Glascoe FP. Parents' concerns about children's development: prescreening technique or screening test? Pediatrics 1997; 99:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/48\">",
"      Paul R, Jennings P. Phonological behavior in toddlers with slow expressive language development. J Speech Hear Res 1992; 35:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/49\">",
"      Olswang L, Rodriquez B, Timler G. Recommending intervention for toddlers with specific language learning disabilities: We may not have all the answers, but we know a lot. Am J Speech Lang Pathol 1998; 7:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/50\">",
"      Bishop DV, Edmundson A. Language-impaired 4-year-olds: distinguishing transient from persistent impairment. J Speech Hear Disord 1987; 52:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/51\">",
"      Thal D, Tobias S, Morrison D. Language and gesture in late talkers: a 1-year follow-up. J Speech Hear Res 1991; 34:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/52\">",
"      Huttenlocher J, Haight W, Byrk A, et al. Early vocabulary growth: Relation to language input and gender. Dev Psychol 1991; 27:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/53\">",
"      Whitehurst GJ, Fischel JE. Practitioner review: early developmental language delay: what, if anything, should the clinician do about it? J Child Psychol Psychiatry 1994; 35:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/54\">",
"      Whitehouse AJ, Robinson M, Zubrick SR. Late talking and the risk for psychosocial problems during childhood and adolescence. Pediatrics 2011; 128:e324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/55\">",
"      Raikes H, Pan BA, Luze G, et al. Mother-child bookreading in low-income families: correlates and outcomes during the first three years of life. Child Dev 2006; 77:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/56\">",
"      High PC, LaGasse L, Becker S, et al. Literacy promotion in primary care pediatrics: can we make a difference? Pediatrics 2000; 105:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/57\">",
"      Zuckerman B. Promoting early literacy in pediatric practice: twenty years of reach out and read. Pediatrics 2009; 124:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/58\">",
"      Huebner C, Meltzoff AN. Intervention to change parent-child reading style: a comparison of instructional methods. Applied Developmental Psychology 2005; 26:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/59\">",
"      Zimmerman FJ, Gilkerson J, Richards JA, et al. Teaching by listening: the importance of adult-child conversations to language development. Pediatrics 2009; 124:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/60\">",
"      Zimmerman FJ, Christakis DA, Meltzoff AN. Associations between media viewing and language development in children under age 2 years. J Pediatr 2007; 151:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/61\">",
"      Christakis DA, Gilkerson J, Richards JA, et al. Audible television and decreased adult words, infant vocalizations, and conversational turns: a population-based study. Arch Pediatr Adolesc Med 2009; 163:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/62/5098/abstract/62\">",
"      Tomopoulos S, Dreyer BP, Berkule S, et al. Infant media exposure and toddler development. Arch Pediatr Adolesc Med 2010; 164:1105.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14339 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5098=[""].join("\n");
var outline_f4_62_5098=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19048305\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048021\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048028\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048035\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048044\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048052\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048059\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048066\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048073\">",
"      Developmental and behavioral conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048080\">",
"      Other diagnoses and contributing factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048087\">",
"      Invalid explanations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048094\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048122\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048129\">",
"      Cautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048136\">",
"      PRIMARY CARE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048144\">",
"      Surveillance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048151\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048158\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048165\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048172\">",
"      Hearing test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048179\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048186\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048221\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048228\">",
"      Referral options",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048270\">",
"      Approach to referral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19048277\">",
"      Role of primary care provider",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048284\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048291\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048298\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19048305\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/14339\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14339|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/62/17379\" title=\"picture 1\">",
"      Scarred tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14339|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/39/27260\" title=\"table 1\">",
"      Language delay red flags",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/8/35980\" title=\"table 2\">",
"      DBP diagnoses with expressive language delay",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/19/9532\" title=\"table 3\">",
"      Etiologies of expressive delay",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/20/16717\" title=\"table 4\">",
"      Major language milestones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/14/24813\" title=\"table 5\">",
"      Speech and language delay resources",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/24/394?source=related_link\">",
"      Childhood lead poisoning: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29209?source=related_link\">",
"      Clinical features of cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=related_link\">",
"      Congenital anomalies of the ear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37480?source=related_link\">",
"      Definitions of specific learning disability and laws pertaining to learning disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/49/26394?source=related_link\">",
"      Developmental-behavioral surveillance and screening in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19050?source=related_link\">",
"      Etiology of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26343?source=related_link\">",
"      Evaluation and treatment of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6409?source=related_link\">",
"      Normal reading development and etiology of reading difficulty in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/17/35097?source=related_link\">",
"      Surveillance and screening for autism spectrum disorders in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4698?source=related_link\">",
"      Terminology, epidemiology, and pathogenesis of autism spectrum disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_62_5099="Ddx intestinal atresia";
var content_f4_62_5099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66065&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of intestinal atresia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Antral web",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pyloric web",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Annular pancreas",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Malrotation and volvulus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Malrotation and Ladd's bands",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Duodenal stenosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ileal stenosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Internal hernia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Congenital bands",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Meconium ileus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Meckel's diverticulum",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hirschsprung's disease",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5099=[""].join("\n");
var outline_f4_62_5099=null;
var title_f4_62_5100="ACOG CPP Rx BC recs";
var content_f4_62_5100=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACOG chronic pelvic pain level B and C recommendations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Recommendations based on limited or inconsistent scientific evidence (level B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle2\">",
"        Indication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GnRH agonists",
"       </td>",
"       <td>",
"        CPP other than endometriosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adhesiolysis",
"       </td>",
"       <td>",
"        CPP attributed to dense bowel adhesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hysterectomy",
"       </td>",
"       <td>",
"        Reproductive tract symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sacral nerve stimulation",
"       </td>",
"       <td>",
"        CPP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physical therapy",
"       </td>",
"       <td>",
"        CPP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nutritional supplementation with vitamin B1 or magnesium",
"       </td>",
"       <td>",
"        Dysmenorrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Injection of trigger points",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        CPP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Application of magnets to trigger points",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acupuncture, acupressor, transcutaneous nerve stimulation",
"       </td>",
"       <td>",
"        Primary dysmenorrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Recommendations based on consensus and expert opinion (level C)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle2\">",
"        Indication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antidepressants",
"       </td>",
"       <td>",
"        CPP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Opioids",
"       </td>",
"       <td>",
"        CPP",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted and modified from Clinical Management Guidelines for Obstetrician-Gynecologists. Number 51, March 2004: Chronic Pelvic Pain. Obstet Gynecol 2004; 103:589.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5100=[""].join("\n");
var outline_f4_62_5100=null;
var title_f4_62_5101="Causes of hearing loss";
var content_f4_62_5101=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of hearing loss",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Conductive",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Outer-ear causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital microtia or atresia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            External otitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Trauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Squamous cell carcinoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Exostosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Osteoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Psoriasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cerumen",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Middle-ear causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital atresia or ossicular chain malformation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Otitis media",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cholesteatoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Otosclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Tympanic membrane perforation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Temporal bone trauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Glomus tumors",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Sensorineural",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Inner-ear causes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hereditary hearing loss",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital viral infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital malformations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Presbycusis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Meningitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Thyrotoxicosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Viral cochleitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Ototoxic drugs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Otologic surgery",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Meniere disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Noise exposure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Barotrauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Penetrating trauma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Acoustic neuroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Meningioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Autoimmune disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Multiple sclerosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cerebrovascular ischemia",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5101=[""].join("\n");
var outline_f4_62_5101=null;
var title_f4_62_5102="Stress echocardiography outcome";
var content_f4_62_5102=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68442&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Presence and extent of wall motion abnormalities on exercise echocardiography predict outcome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 331px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 5375 patients undergoing exercise echocardiography, the mortality during a 10.6 year follow-up was associated with the presence and extent of echocardiography wall motion abnormalties at peak exercise (summed stress score); this correlates with the number of vessels with obstructive lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Marwick, TH, Case, C, Vasey, C, et al, Circulation 2001; 103:2566.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5102=[""].join("\n");
var outline_f4_62_5102=null;
var title_f4_62_5103="Structure AMG 531";
var content_f4_62_5103=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69951&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Structure of romiplostim (AMG 531, Nplate)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 133px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Romiplostim is a \"peptibody\" composed of two disulphide-bonded human IgG1 kappa&nbsp;heavy chain&nbsp;constant regions (Fc fragment) each of which is covalently linked at residue 228 via polyglycine with two identical TPO agonist peptide sequences.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Janet Nichol, Amgen, Inc, Thousand Oaks, CA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_62_5103=[""].join("\n");
var outline_f4_62_5103=null;
